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ABSTRACT
Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model
by
Merrill Russen Landers
Dr. Frank van Breukelen, Examination Committee Chair
Associate Professor of Biology
University of Nevada, Las Vegas
Outside of finding a cure, one of the preeminent goals of research in Parkinson’s
disease (PD) is finding a neuroprotective treatment that when applied prior to the onset
of the disease will decrease the risk and severity of the subsequent disease. One such
treatment that has potential as a neuroprotective agent in PD is exercise. Several
studies have found forced exercise to be protective of Parkinson’s disease in adult
rodent models; however, few of these studies have used a design wherein voluntary
exercise was evaluated. Moreover, no study has used a true neuroprotective design in
which exercise was applied prior to disease onset and throughout the life of the animal.
Therefore, the focus of this dissertation was to further explore the role of a
preconditioning of exercise, both forced and voluntary, in a 6-hydroxydopamineinduced hemiparkinsonian rat model. The research approach adopted in this
dissertation included a randomized control design of forced and voluntary exercise (i.e.,
treadmill and running wheel) applied before and after neurotoxin-induced
hemiparkinsonism. Motor behavior tests were used to assess the outcomes. The
findings from this dissertation provide evidence that exercise, either forced or
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voluntary, does not provide any neuroprotective benefit in terms of protection from
Parkinsonian motor signs and forelimb asymmetry. The collective results of this
dissertation cast doubt on the current body of the literature on exercise
neuroprotection in PD and suggest that the notion that exercise is neuroprotective is
premature.

Keywords: voluntary, forced, exercise, neuroplasticity, Parkinson’s disease, dopamine,
stress
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CHAPTER 1

Parkinson’s disease
Parkinson’s disease (PD), named after the first clinical description by James
Parkinson in 1817, is the most common movement disorder and the second most
common neurodegenerative disease after Alzheimer’s disease (Fahn & Sulzer, 2004).
The age-adjusted annual incidence in the US between the ages of 50 and 99 is 114.7
cases per 100,000 and steeply increases as one ages (Bower et al., 1999). Since PD is
more common with increasing age, its prevalence is expected to triple over the next 50
years due to the aging US population.
PD manifests typically in the sixth decade of life and begins with relatively
modest limitations that progressively cause disability over the next few decades. PD is
characterized by four slowly progressive cardinal signs: bradykinesia (slowness of
movement), rigidity (stiffness), resting tremor, and postural instability (balance
impairment). The cumulative effects of these impairments are often very troubling and
can lead to considerable disability. While the motor deficits associated with PD are not
usually directly life threatening, they contribute to falling which in turn can lead to
severe injuries (e.g., head injuries, fractures, etc.) and hospitalization. Eventually those
with PD may be confined to a wheelchair and may socially isolate themselves from their
regular activities, which stimulates a vicious cycle of decreased physical conditioning
and subsequent increased potential for aspiration pneumonia and falling, which are the
most common causes of mortality in PD. Not surprisingly, patients with PD have an
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increased risk of death as compared to age and gender matched persons (Uitti et al.,
1993). Studies have demonstrated a two to three-fold risk for death in PD as compared
to those without PD, which corresponded to an 8 year decrease in life expectancy
(Morens et al., 1996).
Treatment has not been directed at the causative agent of PD because it is
unknown. Therefore, most treatment has focused on ameliorating the symptoms of the
PD. Unfortunately, these treatment strategies do not stop the progressive degenerative
nature of the disease. Treatment is typically classified into three main categories:
nonpharmacologic, pharmacologic, and surgical. There is no single approach to the
management of PD; however, the most acceptable approach is pharmacologic therapy
using one or more of the following classes of medications: dopamine precursors
(levodopa), dopamine agonists, anticholinergics, catechol-O-methyl tranferase inhibitors
(blocks dopamine metabolism), monoamine oxidase B inhibitors (blocks central
dopamine metabolism), and amantadine.
The most effective pharmacologic treatment for PD, levodopa, has a limited
period of effectiveness (7-12 years) and is associated with irreversible dyskinesias and
motor fluctuations (Poewe et al., 1986; Schrag & Quinn, 2000). Moreover, it is theorized
that its oxidative metabolites may cause free radical formation which theoretically
potentiate the neurodegeneration (Galvin, 2006; Hastings & Zigmond, 1997; J. Xu et al.,
2002; Yu et al., 2005). Because of these reasons, it is generally not given as a first line
therapy even though it is the most effective at reducing the symptoms. Most patients
typically begin with dopamine agonists and usually one or more of the other
2

medications as adjuncts. Because of the monoamine oxidase B inhibitor Deprenyl has
demonstrated a neuroprotective delay of disease onset by 9 months, it has become an
attractive neuroprotective agent (LeWitt, 1991). Unfortunately, no long term positive
effects have been demonstrated so the neuroprotective ability of the drug has been a
source of contention in the literature (Shoulson, 1998).
Aside from the continual search for the neuropathologic etiology of PD and
treatment efficacy studies, attention on neuroprotective strategies in PD has gained
considerable traction (Biglan & Ravina, 2007; Fahn & Sulzer, 2004; Hauser & Zesiewicz,
2006; Kieburtz, 2006; LeWitt, 2004, 2006; Poewe, 2006; Simpkins & Jankovic, 2003) with
as many as 59 potential neuroprotective therapies in various stages of investigation
(Ravina et al., 2003). Some of these putative neuroprotective strategies range from
pharmacologic agents, like pramipexole (Joyce et al., 2004) and Ropinirole (Whone et
al., 2003), to behavioral manipulations like smoking (Papapetropoulos et al., 2005) and
dietary restriction (Mattson et al., 2004). It is hoped that these neuroprotective
strategies will eventually either prevent the disease for those at risk, increase the age of
disease onset for those at risk, decrease the severity of disease at onset, and/or slow
the rate of disease progression once the disease has been acquired.

Etiopathogenesis
PD is characterized by the progressive loss of dopamine producing cells in the
substantia nigra of the midbrain. These dopaminergic neurons project to the basal
ganglia where they release their dopamine into the striatum of the basal ganglia. This is
3

commonly referred to as the nigrostriatal pathway. It is the paucity of dopamine in the
striatum secondary to nigrostriatal attrition that causes the imbalance of motor
facilitation and inhibition resulting in the characteristic features of the disease. Despite
considerable research, it is not known what the etiological trigger of the disease is;
hence, it is commonly referred to as “idiopathic.”
The current etiological theory is that an unknown environmental toxin or toxins
act on genetically susceptible individuals to cause the disease. Unfortunately, the
environmental toxin or toxins remain elusive. In addition, there are only a small
minority of cases that have a known genetic cause. Currently, there are thirteen
different familial types of PD (Table 1) representing a small minority of the cases of PD
(Abeliovich & Flint Beal, 2006). While the link between the environmental toxin and the
genetic susceptibility lacks direct evidence, it represents the leading etiological theory
for the disease.
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Table 1. Known genetic causes of PD (Biskup et al., 2008; Gasser, 2005, 2007).
Locus

Inheritance

Gene

Gene
product

Map
position

PARK1

Dominant

SNCA

α-synuclein

4q21

PARK2

Recessive

Parkin

6q25

PARK3

Dominant

SPR?

465 RING finger
protein, a
ubiquitin E3
ligase
?

PARK4

Dominant

α-synuclein

4q21

PARK5

Dominant

UCH L1

PARK6

Recessive

PINK1

PARK7

Recessive

DJ-1

α-synuclein
triplications
duplications
Ubiquitin Cterminal
hydroxylase L1
PTEN-induced
putative kinase
1
DJ-1

PARK8

Dominant

LRRK2 (leucine
rich repeat
kinase 2)

Dardarin

12 cen

PARK9

AR

ATP13A2

?

1p36

PARK10

Dominant?

?

?

1p32

PARK11

Dominant?

GIGYF2?

?

2q34

PARK12

X-linked

?

?

Zq21

PARK13

Dominant?

OMI/HTRA2

Serine protease

2p12
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Comments
First identified, 3 point
mutations have been
found
Most common cause of
early onset PD (18%)

2p13
Excessive α-synuclein

4p14
1p35-37

Second most common
cause of early onset PD

1p38

DJ-1 knockdown leads
to oxidative stress
susceptibility
Most common genetic
cause of PD (1-6% of US
and Euro PD studies;
29.7% of PD in
Ashkenazi Jews)

The progressive loss of the dopaminergic nigrostriatal neurons in PD underlies
the disease pathogenesis. What triggers this progressive neurodegeneration is not
currently known. However, research suggests that α-synuclein, an intrinsically
unstructured, presynaptic terminal protein, plays a prominent role (Eriksen et al., 2003;
Goedert, 2001). α-synuclein binds to fatty acids and is thought to play a role as a
molecular chaperone and as a regulator of dopaminergic synaptic vesicles (Dev et al.,
2003). α-synuclein is also theorized to play a role in the filling and refilling of
dopaminergic synaptic vesicles (Abeliovich et al., 2000) and in support of this notion has
been shown to be closely associated with synaptic vesicles through
immunohistochemistry (Clayton & George, 1999). Interestingly, absence or inactivation
of α-synuclein in mice models produces only mild, benign behavioral changes (Dev et al.,
2003; Goedert, 2001).
Aggregations of α-synuclein are found in cytoplasmic inclusions of affected
nigrostriatal neurons in those with PD; these inclusions are called Lewy bodies and Lewy
neurites. These Lewy bodies and neuritis are considered the pathological hallmark of
the disease (Figure 1). The presence of these inclusion bodies in nigrostriatal neuron
soma (Lewy bodies) and axons/dendrites (Lewy neuritis) is highly characteristic of the
disease. There are other diseases that also have Lewy body inclusions (e.g., diffuse
Lewy body disease, dementia with Lewy bodies); however, these are found in different
brain regions.
Lewy bodies and Lewy neurites contain high quantities of misfolded and
aggregated α-synuclein, a molecular chaperone, and another protein, ubiquitin, a
6

marker for protein degradation. In normal states, there is a balance between misfolded
proteins and destruction/repair via the ubiquitin-proteosomal system. In PD, it is
theorized that increased rates of misfolded α-synuclein and/or an inefficient ubiquitinproteosomal system are possible mechanisms for the abnormal aggregation and
development of Lewy inclusion bodies. Unfortunately, there is no direct evidence on
what triggers the high rate of α-synuclein aggregation.

Figure 1. Model of disease pathway in PD. Adapted from Goedert (Goedert, 2001).
Genetic factors
(PARK1- PARK13)

Environmental factors

α-synuclein misfolding
and aggregation

Lewy bodies and neuritis
in dopaminergic cells

Nigrostriatal nerve cell
death

It is also not known whether these Lewy structures are an adaptive or
maladaptive cellular response or even if they are the cause of nigrostriatal cell attrition.
Some studies have demonstrated that it is not the Lewy inclusion bodies that are the
problem but rather it is the constituents of these inclusions (i.e., intermediate forms of
α-synuclein) that are the culprits. Whatever the case, all current evidence points to a
7

disease process that consists of a combination of genetic and environmental factors that
triggers a cascade of events (likely via α-synuclein dysfunction and Lewy body
formation) that ultimately results in the loss of dopamine producing nigrostriatal
neurons.

Mitochondrial dysfunction in PD
Some studies have demonstrated that α-synuclein promotes mitochondrial
alterations that may result in oxidative stress and subsequent cell death (Hsu et al.,
2000). Others have shown that intermediate, oligomeric forms (i.e. misfolded) of αsynuclein are toxic to the cells and, therefore, underlie the death of these nigrostriatal
neurons by inhibiting complex 1 mitochondrial respiratory function (Devi et al., 2008).
Mitochondrial dysfunction is thought to be central to the pathogenesis of PD and is
typically complex 1 related (i.e., nicotinamide adenine dinucleotide phosphate
(NADH):ubiquinone oxidoreductase) (Emerit et al., 2004; Mounsey & Teismann, 2010).
Complex 1 respiratory dysfunction, in turn, increases the release of reactive
oxygen species (ROS) (e.g., hydrogen peroxide and superoxide radicals), thereby
increasing the oxidative stress on these cells. Several studies have demonstrated that
cellular oxidative stress plays a prominent role in cellular destruction in PD, likely by
increasing cytosolic cytochrome C and subsequently initiating caspase-mediated
apoptotic signaling pathways (Mounsey & Teismann, 2010; Perier et al., 2007). In
addition, defects in complex 1 respiration lower the threshold for mitochondrialdependent apoptosis, a crucial event in nigrostriatal degeneration (Perier et al., 2005).
8

Increasing oxidative stress, in turn, can increase the susceptibility of α-synuclein
to misfolding (S. Xu et al., 2006). Thus, a vicious cycle of oxidative stress, α-synuclein
misfolding and subsequent α-synuclein aggregation, complex 1 mitochondrial
dysfunction, and nigrostriatal cell death is proposed (Figure 2). This vicious cycle
implicates any potential endogenous or exogenous complex 1 inhibitor as a potential
contributor to the cascade of events that leads to cell death. In addition, it suggests
that any endogenous or exogenous agent that can reduce reactive oxygen species or
oxidative stress may afford neuroprotection.

Figure 2. A vicious cycle of dopaminergic cell death in PD.
Endogenous antioxidants:

Neurotoxicity
Mitochondrial apoptotic pathways

Superoxide dismutase
Catalase
Glutathione peroxidase

Reactive oxygen
species

Oxidative stress

α-synuclein
aggregration

Point mutations in α-synuclein gene
Triplication of α-synuclein gene

Mitochondrial complex 1
dysfunction

Complex 1 inhibitors:
MPTP
6-OHDA
Rotenone
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It is not known what initiates this proposed cycle in PD or whether mitochondrial
dysfunction precedes α-synuclein aggregation or vice versa. However, there is no doubt
that they are intrinsically linked. It is logical to consider that increased dysfunction at
any of the steps in the vicious cycle could trigger or potentiate this cycle. ROS like
superoxide radicals and hydrogen peroxide are the normal byproducts of mitochondrial
respiration and they are typically controlled by a range of antioxidants (e.g., superoxide
dismutase, glutathione peroxidase, catalase); however, in certain pathological states,
like PD, the amount of ROS produced swamps the antioxidant protection mechanisms.
In addition, there is considerable evidence that neuroinflammatory processes may also
play a role by increasing oxidative stress (E. C. Hirsch & Hunot, 2009).
Point mutations in the gene encoding α-synuclein (i.e., PARK1) or abnormally
high levels of α-synuclein caused by PARK4 overexpression may trigger the development
of PD; either of these mechanisms would be sufficient to increase the rate of misfolding
which would then presumably overwhelm the removal capacity of the ubiquitinproteosomal system (Figure 3). However, only a minority of individuals with PD have
these genetic characteristics. In the cases of unknown cause or idiopathic PD, there are
a few possibilities: 1. complex Mendelian inheritance has hindered genetic links (i.e.,
complex inheritance patterns would be incomplete dominance, co-dominance,
polygenic traits); 2. undiscovered environmental triggers have remained elusive; and, 3.
a combination of the previous two.
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Figure 3. Ubiquitin-proteosomal removal of misfolded α-synuclein. Adapted from Pahwa
(Pahwa, Lyons, & Koller, 2003).
Inactive ubiquitin

Activated
ubiquitin

E1

E2 (UbcH7/8)

Misfolded
α-synuclein

Conjugated ubiquitin
E2 (UbcH7/8)

E3

E4?

Parkin
PARK2
26S

Polyubiquitylated
substrate

UCH-L1
(PARK5)

U

Environmental toxins have become the target of considerable research in PD
because they are able to produce oxidative stress, a prominent factor in PD, in animal
models of the disease (Friedrich, 2005). Environmental toxins, like 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), and rotenone cause
Parkinson-like symptoms in primates and rodents; these neurotoxins are also all
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complex 1 inhibitors (Mounsey & Teismann, 2010; Perier et al., 2005). Additionally,
rotenone can produce inclusion bodies with similar characteristics as the human Lewy
inclusion body (Betarbet et al., 2000). Moreover, these inclusions are immunoreactive
to α-synuclein. Thus, these neurotoxins may enter the cycle downstream or as the
initial precipitating factor of the disease (depending on your frame of reference) of the
α-synuclein aggregation and may eventually cause α-synuclein aggregation by increasing
cellular oxidative stress (Figure 2). In support of this notion is indirect preliminary
evidence that rotenone may cause accumulation of α-synuclein in vivo and in vitro
(Betarbet et al., 2006).
Theoretically, any intervention that can slow or stop any of the elements/steps
of this proposed vicious neurodegenerative cycle in PD would logically decrease the
cascade of events that leads to the death of these dopaminergic neurons. Not
surprisingly, anti-oxidant therapies, used to decrease the levels of reactive oxygen
species, have been a PD research focus for many years (LeWitt, 2006; Mounsey &
Teismann, 2010). While no definitive conclusions for any such therapy have been
reached, there has been some progress and some attractive therapies including the
following (Mounsey & Teismann, 2010): Coenzyme Q10 (ubiquinone), creatine, SS
peptides, green tea polyphenols, mulberry wood polyphenol (oxyresveratrol), uric acid,
Cyperus rotundus rhizome (Cyperi rhizome), Uncaria rhynchophylla, Mito-Q10 (Ghosh et
al., 2010). Another promising antioxidant therapy for PD is exercise.
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Exercise in rodent models of PD
Recent rodent research on PD has indicated that exercise may offer robust
neuroprotection to the dopaminergic nigrostriatal neurons after the onset of toxininduced PD. In these studies, exercise not only significantly improved motor function,
but also had a positive impact on the underlying neurochemical disorder of PD (i.e., loss
of nigrostriatal dopamine) (Cohen et al., 2003; Howells et al., 2005; Tillerson et al., 2003;
Tillerson et al., 2001). Tillerson et al (2001) demonstrated that forced exercise of rats
with PD, induced by 6-hydroxydopamine (6-OHDA), significantly improved motor
function (Tillerson et al., 2001). Moreover, this motor improvement was coupled with
significant sparing of the concentration of striatal dopamine and its metabolites,
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). In addition, a
relatively high concentration of a protein responsible for sequestering dopamine in its
synaptic vesicles, vesicular monoamine transporter (VMAT2), was consistent with the
high concentrations of dopamine and its metabolites. VMAT2 levels are considered to
be a highly reliable marker of the integrity of dopamine terminals (Kilbourn et al., 1993;
Kilbourn et al., 1996; Miller et al., 1999a; Miller et al., 1999b). In a similar study,
Tillerson et al (2003) demonstrated similar findings using a forced treadmill running
protocol on a 6-OHDA rat model and a MPTP mouse model (Tillerson et al., 2003).
Again, treadmill exercise improved motor function and increased levels of dopamine,
DOPAC, HVA and VMAT2. In addition, levels of several presynaptic proteins of
dopaminergic neurons were also improved by exercise, including dopamine transporter
(DAT) and tyrosine hydroxylase (TH), which is the rate limiting enzyme in dopamine
13

biosynthesis. Work by Poulton and Muir (2005) and Howells et al (2005) confirmed
previous findings that exercise in the 6-OHDA rat model is neuroprotective (Howells et
al., 2005; Poulton & Muir, 2005). Collectively, these findings suggest that exercise may
have a direct protective effect on the neurochemical pathophysiology of PD rather than
simply ameliorating its signs and symptoms through improved musculoskeletal fitness.
Exercise may not only be beneficial in the disease state of PD (i.e., after disease
onset), but may also be protective to dopaminergic neurons and the development of
PD. Cohen et al (2003) demonstrated that exercise prior to toxin-induced PD (6-OHDA)
in rats produced profound neuroprotection of nigrostriatal neurons (Cohen et al., 2003).
In addition, exercised rats, in contrast to control rats, had less in the way of motor
deficits that are characteristic of this PD model. Thus, forced exercise prior to 6-OHDA
lesioning resulted in a milder PD symptom profile compared to rats that were not forced
to exercise. Three conclusions can be drawn from these results: 1. forced exercise
prevents the development of behavior deficits characteristic of the 6-OHDA lesion
model; 2. forced exercise attenuates the loss of striatal dopamine; and, 3. forced
exercise increases striatal glial-derived neurotropic factor (GDNF). This last finding was
important because it provided evidence that GDNF may be an underlying
neuroprotective mechanism for dopaminergic cells from 6-OHDA insult. This is
consistent with evidence from other studies which have demonstrated GDNF as a
potent protector of dopaminergic neurons (Akerud et al., 1999; Choi-Lundberg et al.,
1998; Gong et al., 1999; Hoffer et al., 1994; Jaumotte & Zigmond, 2005; Kearns & Gash,
1995; Kramer et al., 1999; Lin et al., 1993; Schatz et al., 1999). GDNF is thought to
14

protect neurons by acting as a neurotrophic factor in providing nourishment to neurons.
Unfortunately, there are big gaps in how GDNF accomplishes the protection. Moreover,
there is no other evidence in the literature about the effect of exercise on the actual
etiological processes of the disease (e.g., oxidative stress). Results from the
aforementioned studies certainly warrant further investigation into the physiologic
processes at the cellular level.
Enriched environments, which have a voluntary exercise component to go along
with social interaction and learning, have also been shown to improve motor function
and to resist MPTP insult in mice PD models. These studies have demonstrated
decreased loss of striatal dopamine and dopamine-related transporters (i.e., DAT and
VMAT2) (Bezard et al., 2003; Faherty et al., 2005; Jadavji et al., 2006). In addition,
Faherty et al (2005) also demonstrated a concomitant upregulation of GDNF (Faherty et
al., 2005). Interestingly, social rats (i.e., housed with several other rats) without a
running wheel also exhibited good improvement.
Enriched environments (Bezard et al., 2003) and exercise (Neeper et al., 1995;
Russo-Neustadt et al., 2000; Widenfalk et al., 1999) have also been shown to
significantly increase another possible neuroprotective agent, brain-derived
neurotrophic factor (BDNF). In many other studies, neuronal growth factors, such as
GDNF and BDNF, are capable of protecting cells against oxidative stress (Williams, 1995),
which has been consistently documented as a potential mechanism behind protein
misfolding and dopaminergic cell depletion in PD.
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Forced inactivity (i.e., restricted movement) prior to or after neurotoxin-induced
PD has resulted in an exacerbation in motor function deficits and neurochemical loss
(Tillerson et al., 2002b). Forced inactivity prior to a mild dose of 6-OHDA, which would
not normally produce behavioral or neurochemical deficits, not only led to significant
behavioral deficits but also resulted in an exacerbation of striatal dopamine, DOPAC and
HVA loss as well as significant decreases in DAT, VMAT2, and TH. Thus, by forcing a rat
to be inactive (i.e., restricted movement) it causes an appearance of more severe PD
symptoms with an associated worsening of nigrostriatal neurochemical function. In the
control rats (no movement restriction and same mild 6-OHDA dose) there were no
observable PD symptoms and nigrostriatal neurochemistry was not distinguishable from
rats that had had a sham neurotoxin. Thus, forced inactivity turns a very mild 6-OHDA
lesion, which produces no PD symptoms and does not affect nigrostriatal chemistry, into
a symptom and PD profile that is consistent with a much larger lesion.
Following severe 6-OHDA exposure and forced recovery, forced inactivity caused
a return of motor behavior deficits and a decrease in dopamine, DOPAC, HVA, DAT,
VMAT2, and TH (Tillerson et al., 2002b). The implication of these findings is that
exercise salvages these dopamine cells, but the neuroprotection is fragile and needs to
be maintained by regular exercise. Recently, Caudel et al (2007) demonstrated that
decreased physical activity or movement during the process of nigrostriatal damage is
not merely a symptom of dopamine loss but may contribute to an exacerbation in
neurochemical and behavioral asymmetry in MPTP mice (Caudle et al., 2007). Some
authors have reported that an overall decrease in physical activity precedes the onset of
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the cardinal symptoms in human PD (Comella et al., 1994; Fertl et al., 1993; Mazzoni &
Ford, 1999; Toth et al., 1997). This led Tillerson et al (2002) to hypothesize that
decreased physical activity is not only a symptom of PD, but perhaps a catalyst in the
neurodegenerative process of PD (Tillerson et al., 2002b).
There is not a perfect animal model for PD (Ceravolo et al., 2006; Lang, 2006).
There are some issues with the sudden onset of PD symptoms produced by neurotoxins
in rat and mouse models. In human PD, the neurodegenerative process is
comparatively slow and progressive, whereas, in the toxic rodent model the
neurodegeneration is acute and sudden (Galati & Di Giovanni, 2010; Lang, 2006). Also,
neurodevelopment, plasticity, life span and degeneration are also on different
trajectories in the rodent models compared to human PD. However, the MPTP (mouse
and primate) and 6-OHDA (rat) models of PD are the most commonly used models of PD
and have shed some important light on the many different putative neuroprotective
therapies. Translating these neuroprotective therapies into human clinical research has
not yet proved fruitful at this time. Therefore, clinicians and researchers should
cautiously generalize the aforementioned animal findings on exercise to human PD.
However, it should be remembered that rodent models of PD are of merit because they
offer important direct data on the shared neurobiology of the nigrostriatal pathways
that are affected in PD. This cannot be done to the same extent in human PD.
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Exercise in non-pathologic rodent models that relates to PD
Exercise causes a plethora of benefits in rodent models, some of which are
relevant to PD. Exercise has been shown to improve performance in learning and
memory tasks in rat models (Radak et al., 2001) and enhance brain plasticity (Cotman &
Berchtold, 2002; Cotman & Engesser-Cesar, 2002). If has been shown to increase serum
calcium levels which is then transported to the brain where it stimulates dopamine
through a calcium/calmodulin-dependent system (Sutoo & Akiyama, 2003). Exercise is
also associated with Hsp70 induction in the muscles of treadmill running rats (Noble et
al., 2006).
Exercise has been shown to increase levels of antioxidants enzymes in rodent
muscle (Ji, 1993; Powers et al., 1993) and brain (Liu et al., 2000; Somani et al., 1995;
Teixeira et al., 2008). However, none of these researchers investigated the antioxidant
levels in the substantia nigra where nigrostriatal cells degenerate in PD. Therefore, the
next logical step would be to determine if, in fact, the antioxidant levels would increase
as a result of exercise in a brain region immediately relevant to the neurodegeneration
of PD. Linking an increase in exercise-induced antioxidants to the proposed vicious cycle
of dopaminergic cell death in PD would be an important neurobiological finding for PD
and other neurodegenerative diseases that have similar molecular neuropathology (i.e.,
Alzheimer’s disease). Such a link would also provide an attractive, evidenced-based
rationale for ameliorating the underlying disease course in PD.
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Exercise in human PD
At present, there is no direct evidence that exercise is neuroprotective in human
PD. However, there is some downstream evidence of the neuroprotective potential of
exercise in human PD. First, physical exercise has been shown to be beneficial in
persons with PD (Crizzle & Newhouse, 2006; de Goede et al., 2001; Suchowersky et al.,
2006b). This benefit is mostly in the form of motor function improvements. In addition,
recent epidemiologic research suggests that exercise may offer some protection against
PD. Based on their study of 48,574 men and 77,254 women, Chen et al (2005) reported
that physical activity or strenuous exercise in early adult life was inversely related to PD
risk in men (Chen et al., 2005). Strenuous exercise was associated with a 60% lower PD
risk in men. It was also found that men with PD were consistently less physically active
than men without PD up to 12 years prior to diagnosis. However, this inverse
relationship was not demonstrated with statistical significance (p = 0.06) in women.
Sasco et al (1992) also reported a slight protective effect of moderate to heavy sports
participation in adulthood on the risk for PD in a study of 50,002 men (Sasco et al.,
1992). It has also been reported that in young onset PD “…early exposure to well water
drinking and head trauma may trigger and expedite the appearance of PD features, but
such acceleration may be prevented through regular exercise” (Tsai et al., 2002). Taken
together, these studies seem to support the data from rodent PD models of exercise in
that exercise may offer neuroprotection to relevant pathways in PD.
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Summary
Parkinson’s disease is a common neurodegenerative that causes a gradual but
profound loss of functioning in the life of those affected. Treatment is mostly palliative
and does little to disrupt the degenerative process. In lieu of the elusive cure, some
researchers have focused their attention on discovery of neuroprotective treatments
that can affect the underlying disease course by preventing the onset of the disease or
by slowing it down. However, discovering neuroprotection in PD has proven difficult
and at present there has been little success (Antonini, 2011; Biglan & Ravina, 2007;
Galati & Di Giovanni, 2010; Hauser & Zesiewicz, 2006; Kieburtz, 2006, 2010; Lang, 2006;
LeWitt, 2006; Poewe, 2006). So far, no treatment has been shown to significantly slow
the progression of the disease (Suchowersky et al., 2006a). However, it remains an
important goal in PD research and warrants investigation.
In this dissertation, the overarching goal that guided the designs was to verify
the role exercise as a viable and valid neuroprotective agent in a toxin-induced
hemiparkinsonian rat model. To accomplish this goal, three different aims were
analyzed using comparative-control designs. The first aim (Chapter 2) addressed the
role of 4 weeks of forced exercise and no exercise in rats after a toxin-induced
hemiparkinsonian. The intent of this aim and subsequent design was to determine if
exercise prevented motor asymmetry after experimental lesioning. The second aim
(Chapter 3) involved a 4-week preconditioning of exercise prior to induction of
hemiparkinsonism. The hypothesis of this aim was that exercise prior to toxin-induced
hemiparkinsonism would prevent motor asymmetry relative to no exercise. The third
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aim (Chapter 4) was to compare 6 weeks of forced and voluntary exercise compared to
a control group and a sham lesioned group. This design was cast to determine if
exercise was protective against behavioral motor asymmetry; however, more
importantly, it was cast to determine if a stressful running condition (forced exercise)
was more protective than a non-stressed running condition (voluntary exercise).
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CHAPTER 2
Forced exercise after induction of 6-OHDA-mediated nigrostriatal insult:
neuroplasticity in an adult hemiparkinsonian rat model

Abstract: Forced exercise has been shown to ameliorate behavioral symptoms in an
adult rat model of Parkinson’s disease (PD). Importantly, forced exercise has been
shown to increase dopamine and nerve growth factors; this suggests that it might affect
the underlying disease course. However, there are a few studies that have found mixed
results in the rodent PD model after PD induction with neurotoxin. Therefore, the
purpose of this study was to explore the role of a forced exercise after toxin-induced PD
in rats in decreasing behavioral asymmetry. Hemiparkinsonian symptoms were induced
using a unilateral injection of 6-OHDA in the right medial forebrain bundle. Rats were
then randomized into two 4-week experimental conditions, an exercise condition and a
non-exercise control condition. Parkinsonian behavioral tests (i.e., apomorphine
rotations, forelimb placement asymmetry, exploratory rearing) did not show any
significant differences over time between the two groups. These results are not
consistent with previous research that has found a positive treatment effect with
exercise and cast doubt on the claims that exercise after neurotoxin induced-PD
recovers hemiparkinsonian symptoms.
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative disease due to
attrition of dopaminergic nigrostriatal fibers. It characteristically produces the following
cardinal signs: bradykinesia, resting tremor, postural instability and rigidity. Many of the
behavioral and neurochemical alterations in PD can be modeled in rats by using a
unilateral infusion of the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) into
the nigrostriatal fibers. In this rat hemiparkinsonian model, the unilateral infusion of 6OHDA will cause an asymmetry of movement (hemiparkinsonism) in the rat forelimb
that can be used to determine the severity of parkinsonian symptoms. Importantly, 6OHDA animals with severe destruction of the nigrostriatal system (>95%) will not display
any behavioral recovery; however, a less severe lesion (>80%) will demonstrate some
behavioral recovery-associated neuroadaptation (e.g., increased dopamine synthesis) in
the remaining dopaminergic neurons (Tillerson & Miller, 2002).
Decreased physical activity during the degenerative process has been shown to
exacerbate behavioral and neurochemical loss in unilateral parkinsonian rats. Tillerson
et al (2002) found that forced-nonuse, which is akin to decreased activity, during the
first 7 days post-lesion caused a marked increase in impairment compared to rats that
were not restrained (Tillerson et al., 2002b). While this is not the same as implementing
exercise after neurotoxin-induced hemiparkinsonism, it does highlight the fact that
there may be a dose dependent relationship to physical activity during the
neurodegenerative process of the disease.
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Much like animal models of cortical injury, forced exercise in the unilateral 6OHDA rat model has been shown to decrease the behavioral and neurochemical deficits
associated with the disease. Tillerson et al (2001) found that moderate exercise
initiated soon after unilateral insult resulted in an attenuation of dopaminergic loss and
a sparing of behavioral impairment (Tillerson et al., 2001). The characteristic limb-use
asymmetry was absent in rats that were forced to run, whereas those rats that were in
the sedentary control maintained a marked limb-use asymmetry throughout the course
of the experiment. In another study by Tillerson et al, exercise following nigrostriatal
damage reduced motor symptoms and increased dopamine and its metabolites in the 6OHDA hemiparkinsonian model (Tillerson et al., 2003). Tajiri et al (2010) found that
forced exercise initiated immediately after a 6-OHDA lesion was better than sedentary
rats in terms of motor recovery; using bromodeoxyuridine (BrdU) to label proliferating
cells, they demonstrated that exercised rats had a significant preservation of tyrosine
hydroxylase positive cells in the striatum and substantia nigra (Tajiri et al., 2010).
Exercise has also driven similar findings in the MPTP (1-Methyl-4-Phenyl-1,2,3,6Tetrahydropyridine) mice model of PD (Fisher et al., 2004).
While previous studies have shown improvements in the motor recovery of the
Parkinsonian rat by forcing them to exercise, a more important finding was that the
exercise improved the levels of dopamine in relevant brain areas. This suggests that
forced exercise may actually affect the underlying disease course by preserving
dopaminergic neurons. While this provides some indirect information that exercise may
mitigate the damage to dopaminergic neurons, there is no direct evidence to explain
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why these dopaminergic neurons are preserved and, importantly, what influence forced
exercise has on the underlying molecular causes of dopaminergic cell loss (i.e.,
apoptosis). Therefore, the primary purpose of this study was to explore the role of
forced exercise after 6-OHDA-induced nigrostriatal dysfunction in a hemiparkinsonian
rat model.

METHODS
Overall study design
Twenty-six male Long Evans rats (Charles River Laboratories, Hollister, California,
USA) aged 91-100 days were used for this experiment. All handling and procedures
were in accord with NIH Guide for the Care and Use of Laboratory Animals and
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use
Committee. The rats first received a unilateral Parkinsonian lesion as described below
and then were randomly assigned into one of two 4-week treatment conditions:
exercise and non-exercise control (Figure 4). These rats, housed individually and fed ad
libitum, weighed between 360 and 457 grams (mean=400.4 grams, SD=24.8) at the time
of randomization. Rats were tested for PD severity using behavioral tests prior to and
after the treatment conditions. Three different behavioral tests were used to create a
comprehensive assessment of the PD severity (Metz & Whishaw, 2002).
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Figure 4. Overall study design.
26 male, Long
Evans Rats
360-457 grams
1 week acclimatization
Unilateral 6-OHDA lesion
(3 rats died during surgery)
1 week period to allow Parkinsonian symptoms to develop
Random assignment
12 rats: Exercise condition
4 weeks

•
•
•

Motor behavior tests:
Apomorphine rotations
Forelimb placing asymmetry
Exploratory rearing

11 rats: Control condition
4 weeks

Surgical procedures
After a one-week acclimatization period, animals were anesthetized using an
intraperotoneal injection of 75 mg/kg Ketamine and 0.25 mg/kg dexmedetomidine. In
order to block noradrenergic uptake sites and thereby prevent noradrenergic toxicity,
15 mg/kg desipramine hydrochloride dissolved in saline was injected intraperotoneally
30 minutes before the neurotoxin was injected (Anstrom et al., 2007; O'Dell et al.,
2007). The rats were then placed in a stereotactic frame (Kopf 900, David Kopf
Instruments, Tujunga, California, USA).
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The scalp was shaved, swabbed with povidone-iodine topical antiseptic and a
central incision was made to expose the skull and bregma. A 1 mm burr hole was then
drilled through the cranium to gain exposure to the cranial cavity at the following
stereotactic coordinates: 3.3 mm posterior to bregma, 1.9 mm lateral, 8.2 mm ventral to
skull surface (Paxinos & Watson, 1998; Paxinos et al., 1985; Tillerson et al., 2003;
Tillerson et al., 2002b). A unilateral Parkinsonian lesion was induced with 10 μg of 6hydroxydopamine hydrobromide in 0.1% ascorbic acid (6-OHDA; Sigma, St. Louis, USA)
or 2,4,5-trihydroxyphenethylamine in 4 μl of 0.9% saline injected into the right
nigrostriatal fibers that make their way to the striatum via the medial forebrain bundle
(Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003; Tillerson et al., 2002b;
Tillerson et al., 2001). This infusion would equate to roughly an 80% loss of
dopaminergic cells (Tillerson et al., 2003). A 28-guage 5 μl-microliter syringe (Hamilton,
Reno, Nevada) was used to slowly inject the 6-OHDA at a rate of 1 μl/min for 4 minutes
into the right medial forebrain bundle.
Following injection of the neurotoxin, the burr hole was closed using bone wax
and standard suturing techniques were used to close the incision. During the surgery
and recovery, rats were kept warm using a warm heating pad and heating lamp. Rats
were brought out of surgical analgesia using 1ml/kg atipamezole (subcutaneous
injection into the flank). Rats received postoperative analgesia daily for three days using
a 0.01mg/kg subcutaneous injection of buprenorphine into the flank. During surgery,
three rats died. Therefore, the remaining 23 rats were randomized into the two
experimental conditions.
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Parkinsonian behavioral testing
After a one week post-surgical recovery period, the rats were tested to
determine their motor behavioral severity of PD prior to entry into the experimental
conditions. After the 4-week experimental period, the rats were tested again with the
same tests of PD motor severity. This was done using apomorphine-induced rotations,
forelimb placement asymmetry, and exploratory rearing.
Due to neurotoxin-induced denervation, the dopamine receptors on the affected
side (i.e., injected side) become hypersensitive in the hemiparkinsonian rat.
Apomorphine, a dopamine agonist, stimulates these receptors causing an asymmetrical
increase in striatal activity on that side relative to the non-affected side. This causes a
rapid, repetitive turning of the body away or contralateral from the lesioned side (Da
Cunha et al., 2008). The number of complete 360° turns within 30 minutes in a round
bowl has been shown to correlate well with lesion severity in terms of dopaminergic cell
loss (Hudson et al., 1993; Metz & Whishaw, 2002). Thus, it was felt that apomorphineinduced rotations would be a good indicator of the severity of the hemiparkinsonian
lesion. Animals were injected with 0.5mg/kg apomorphine hydrochloride (Sigma, St.
Louis, USA) dissolved in saline subcutaneously and then immediately videotaped from
above (Joghataie et al., 2004; Mabandla et al., 2004; Roghani & Behzadi, 2001; Tillerson
et al., 2002b). The number of times the animal rotated 360° in each direction over a 30minute period was counted using the videotape at a later time. The number of
ipsilateral rotations subtracted from the number of contralateral rotations resulted in a
net number of contralateral rotations (Poulton & Muir, 2005).
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Forelimb placement asymmetry while rearing in a cylinder was evaluated using
similar protocols established in previous studies (Moroz et al., 2004; O'Dell et al., 2007;
Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson et al.,
2002b). Each rat was placed in a 22 cm diameter by 26 cm high cylinder for 10 minutes
and videotaped from above. As the rats explored the walls of the cylinder during
rearing, they used one or both forelimbs to contact the wall for support during
exploration. Independent use of the impaired, which would be the left forelimb since
the contralateral nigrostriatal fibers were lesioned, and unimpaired (right forelimb)
forelimbs were counted for each rearing episode. These values were then scored using
the following asymmetry ratio: (Right - Left)/(Right + Left + Both)(O'Dell et al., 2007).
Scores on the asymmetry ratio range from -1 to 1 with a high positive ratio being
suggestive of a greater use of the unimpaired forelimb over the impaired forelimb. A
negative asymmetry ratio would be indicative of greater use of the impaired forelimb
relative to the unimpaired forelimb. Thus, a high positive asymmetry ratio would be
consistent with a hemiparkinsonian lesion.
The number of times that a rat reared during a 10 minute videotaped period was
referred to as exploratory rearing. While this has not been documented previously in
the literature, it was felt that exploratory rearing would be a potential new behavioral
test for hypokinesia which is a common symptom of PD.
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Exercise protocol
Immediately after behavioral testing, the 23 rats were randomly assigned into
one of two 4-week experimental conditions: exercise and control. The control condition
consisted of 11 rats that were housed individually with no exercise equipment and were
not exposed to any exercise for 4 weeks. The exercise condition consisted of 12 rats,
one of which became ill and died (cause unknown per veterinarian) during the 4-week
forced exercise regimen. This exercise condition consisted of forced exercise using a rat
treadmill (Exer 3/6 Treadmill from Columbus Instruments, Columbus, Ohio, USA) five
days per week for 4 weeks during the light cycle. The rats received 2 bouts of 15 minute
running periods (separated by at least 1 hour) per day at a speed of 15 meters per
minute (Tillerson et al., 2003). The Exer 3/6 Treadmill is equipped with an electrical grid
on the posterior portion of the treadmill. If the rats’ tail or hind limb made contact with
the grid, an electrical stimulus strong enough to elicit an aversive reaction would serve
as a negative reinforcer for running noncompliance. The electrical stimulus was set at
200 millisecond pulses with an adjustable pulse repetition rate of 1 to 4 per second. The
intensity was adjustable from 0.35 mA to 3.4 mA and depended on the responsiveness
of the particular rat to the stimulus.

RESULTS
Apomorphine rotations. A 2 (time: pre and post) X 2 (condition: exercise and nonexercise control) mixed factorial ANOVA was conducted to determine if there was an
interaction between time and condition on apomorphine rotations. There was no
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interaction between the variables for apomorphine rotations, P = 0.121 (power = 0.338;
Table 2, Figure 5). There was, however, a significant main effect for time (P < 0.001;
Table 3) suggesting that, regardless of experimental condition, there was an increase in
apomorphine rotations from the pre (mean=188.4, SD=71.4) to the post (mean=284.6,
SD=71.5). There was no main effect for condition (p=.906; Table 4).

Table 2. Descriptive statistics of apomorphine rotations.

Pre
Post

Condition

Mean

Runners
Non-runners
Runner
Non-runners

179.6
197.2
296.8
272.5
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Std.
Deviation
53.1
87.8
73.7
70.5

N
11
11
11
11

Figure 5. Interaction of time and condition on apomorphine rotations.

Runners

Non-runners

400
Apomorphine rotations

350
300
250
200
150
100
50
0
Pre

Post

Figure 5. Means and standard deviations for the number of apomorphine-induced
contralateral rotations during a 30-minute testing period for runners and non-runners
before and after 4 weeks of experimental treatment.

Table 3. Main effect for time on apomorphine rotations.
Time

Mean

Std.
Error

Pre
Post

188.4
284.6

15.5
15.4

95% Confidence Interval
Lower
Upper
Bound
Bound
156.1
220.6
252.6
316.7
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Table 4. Main effect for condition on apomorphine rotations.
Condition

Mean

Std.
Error

Runners
Non-runners

238.2
234.8

19.8
19.8

95% Confidence Interval
Lower
Upper
Bound
Bound
196.9
279.5
193.5
276.1

Forelimb placement asymmetry. A 2 (time: pre and post) X 2 (condition: exercise and
non-exercise control) mixed factorial ANOVA was conducted to determine if there was
an interaction between time and condition on forelimb placements. There was no
interaction for forelimb placement asymmetry, P = 0.497 (power = 0.101; Table 5, Figure
6). There was a main effect for time (P < 0.001; Table 6) which suggests that all of the
animals had significant asymmetry at the pre measurement (72.9% unimpaired over
impaired forelimb use) which decreased significantly at the post measurement (38.4%
unimpaired over impaired forelimb use). There was not a significant main effect for
experimental condition (P = 0.341, power = 0.153; Table 7).

Table 5. Descriptive statistics for forelimb placement asymmetry.

Pre
Post

Condition

Mean

Runners
Non-runners
Runners
Non-runners

.758
.700
.460
.309

Std.
Deviation
.304
.272
.334
.273
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N
11
11
11
11

Figure 6. Interaction of time and condition on forelimb placement asymmetry.

Forelimb placement asymmetry

Runners

Non-runners

1.2
1
0.8
0.6
0.4
0.2
0
Pre

Post

Figure 6. Means and standard deviations of the forelimb placement asymmetry ratio
during a 10-minute testing period for runners and non-runners before and after 4 weeks
of experimental treatment.

Table 6. Main effect of time for forelimb placement asymmetry.
Time

Mean

Pre
Post

.729
.384

Std.
Error
.062
.065

95% Confidence Interval
Lower Bound
Upper Bound
.601
.858
.249
.520

Table 7. Main effect of group for forelimb placement asymmetry.
Condition

Mean

Runners
Non-runners

.609
.504

Std.
Error
.076
.076

95% Confidence Interval
Lower Bound
Upper Bound
.451
.767
.346
.663
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Exploratory rearing. A 2 (time: pre and post) X 2 (condition: exercise and non-exercise
control) mixed factorial ANOVA was also used to determine if there was an interaction
for exploratory rearing. There was not a statistically significant interaction between
time and condition, P = 0.315 (power = 0.166; Table 8, Figure 7). There was not a main
effect on condition, P = 0.260 (power = 0.166; Table 9); however, there was a main
effect on time (P < 0.001; Table 10) with less exploratory rears at the pre measurement
(mean = 6.6, SD = 0.9) compared to the post measurement (mean = 14.5, SD = 1.3).

Table 8. Descriptive statistics for the number of exploratory rears.

Pre
Post

Condition

Mean

Runners
Non-runners
Runners
Non-runners

7.0
6.2
16.3
12.8
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Std.
Deviation
4.1
4.3
6.1
6.3

N
11
11
11
11

Figure 7. Interaction between time and condition on exploratory rearing.

Runners

Non-runners

Exploratory rearing

25
20
15
10
5
0
Pre

Post

Figure 7. Means and standard deviations of the number of exploratory rearing episodes
during a 10-minute testing period for runners and non-runners before and after 4 weeks
of treatment.
Table 9. Main effect of condition on exploratory rearing.
Condition

Mean

Runners
Non-runners

11.6
9.5

Std.
Error
1.3
1.3

95% Confidence Interval
Lower Bound
Upper Bound
8.9
14.4
6.8
12.2

Table 10. Main effect of time on exploratory rearing.
time

Mean

Std. Error

Pre
Post

6.6
14.5

0.9
1.3

95% Confidence Interval
Lower Bound
Upper Bound
4.7
8.5
11.8
17.3
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DISCUSSION
Results of this study do not support the notion that exercise after neurotoxininduced hemiparkinsonism is beneficial. In general, treadmill trained animals did not
improve more than sedentary non-runners in any of the three behavioral tests. Of these
tests, all of the rats regardless of group, runner and non-runner, improved in two of the
outcome tests (i.e., forelimb placement asymmetry, exploratory rearing) and got worse
in one (i.e., apomorphine rotations). The results of this study are not consistent with
the literature and cast doubt on previous assertions of the robustness of the
neuroprotective treatment effect of exercise in an adult 6-OHDA rat model of PD.
A majority of previous research suggests that exercise ameliorates motor deficits
in the 6-OHDA model of PD (Howells et al., 2005; Mabandla et al., 2004; Moroz et al.,
2004; O'Dell et al., 2007; Smith & Zigmond, 2003; Tajiri et al., 2010; Tillerson et al., 2003;
Tillerson et al., 2001; Vergara-Aragon et al., 2003) and also in other rodent models of PD
(Caudle et al., 2007; Fisher et al., 2004). These studies served as the theoretical
foundation for the present study. While there were some differences in the modality of
the exercise regimen, the overall study designs were fairly consistent. The dosing of the
exercise in the present study was consistent with several of the studies (Poulton & Muir,
2005; Tajiri et al., 2010; Tillerson et al., 2003); however, the dosing in the present study
was more intense than the Moroz et al study (2 weeks of 15-30 minutes of running in
plastic balls) and the Mabandla et al study (2 weeks of exercise in free running wheels
(average of 4361 revolutions per day)) (Mabandla et al., 2004; Moroz et al., 2004). Only
the O’Dell et al (2007) study had a more intense exercise protocol (4 weeks of voluntary
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running wheel for >1000 meters/day plus 10.5 meters per minute for 30 minutes of
forced running) (O'Dell et al., 2007). Since the exercise dosing for the present study was
consistent with the previous studies that showed a treatment effect with exercise, it is
not likely that the lack of treatment effect in the present study had anything to do with
the dosing of the treadmill exercise.
While the results of this study were not consistent with the body of the literature
on rodent exercise and PD, there was another study that likewise did not find an
exercise treatment effect. Poulton and Muir (2005) found that treadmill training did not
affect behavioral deficits in the 6-OHDA Parkinsonian rat model (Poulton & Muir, 2005).
This study had an exercise protocol (4 weeks of 40 minutes/day at 13 meters/minute)
that was similar in duration and intensity. Taken together, the results of the present
study and those of Poulton and Muir (2005) study cast doubt on the positive treatment
effect of exercise reported after 6-OHDA injection. In light of this lack of consensus in
the literature, further research is warranted.
The reason for the worsening (i.e., increase in the number of contralateral
rotations) in the apomorphine rotations over time in both of the groups is likely a
function of the time it takes for the neurotoxin to cause oxidative damage and eventual
apoptosis (Cerruti et al., 1993; Crocker et al., 2001; Decker et al., 1993; Glinka et al.,
1997; Hudson et al., 1993). Generally, it is thought that it takes 1-2 weeks in the 6OHDA model. However, some researchers suggest that the neurotoxic effects of 6OHDA continue to cause apoptosis well past 2 weeks and even up to 28 days after the
injection (Bjorklund et al., 1997). In the present study, the pre measurement was taken
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approximately 1 week after the 6-OHDA lesion; this would have been at the early end of
the range of dopaminergic toxicity. The post measurement was taken approximately
five weeks after the 6-OHDA injection; presumably, the full effect of the neurotoxin
would have been realized by that point. Thus, it is logical that the apomorphine
rotations had increased over the duration of the study because the toxicity of 6-OHDA
on the dopaminergic neurons was protracted.
One of the most logical reasons for a lack of treatment effect was the delay in
treadmill treatment following the 6-OHDA lesioning. In the present study, the animals
started the exercise regimen 7 days after the lesioning. Tillerson et al (2001) reported
that exercise started early in the first week after surgery, but not after the first week,
prevented the preferential use of the unimpaired forelimb and reduced contralateral
apomorphine rotations (Tillerson et al., 2001). Indeed, in the studies where a positive
exercise treatment effect was observed, the start for exercise after 6-OHDA lesioning
was very soon after the injection of the neurotoxin: 2-4 hours post-lesioning (Tillerson et
al., 2003), and 4-5 hours post-lesioning (Moroz et al., 2004), and 24 hours (Howells et
al., 2005; Mabandla et al., 2004; O'Dell et al., 2007; Tajiri et al., 2010). While it appears
that early intervention is an important component of neuroprotection, it should be
noted that early exercise may have increased blood flow in behaviorally relevant brain
locations (i.e., nigrostriatal pathways) and this may have actually flushed neurotoxin
from that brain region. Thus, the neuroprotective effect of exercise may not have been
mediated by an effect on the underlying disease course. However, this is purely
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speculative but could, if true, represent a threat to the validity of exercise as a
neuroprotective agent in neurotoxin-induced PD.
Only one study with a positive exercise treatment effect reported an exercise
start time beyond the one week window (i.e., 21 days post lesion)(Vergara-Aragon et al.,
2003). However, it should be noted that in the Poulton and Muir (2005) study, where no
exercise treatment effect was observed, the start time for the early group was 24 hours
after surgery and the late group was 1 week after surgery (Poulton & Muir, 2005).
While there is not complete consensus, taken together, it appears that exercise should
begin soon after 6-OHDA lesioning because it may interfere with the slowly developing
dopaminergic toxicity (i.e., 1-2 weeks). It is possible that an early window of
opportunity may have been missed because of the delayed start in the implementation
of the forced exercise. This represents a limitation in the design of the present study.
Another logical reason for the lack of a positive exercise treatment effect is that
exercise protocol-related stress may have negated the beneficial effects of exercise.
Howells et al found that exercise does improve hemiparkinsonian behavioral symptoms;
however, mild stressors may cancel the neuroprotection afforded by the voluntary
exercise (Howells et al., 2005). Moroz et al (2004) also reported that repeated saline
injections (a form of stress) to rats with free access to running wheels cancelled the
beneficial effects of exercise (Moroz et al., 2004). In the present study, a “forced”
exercise protocol was utilized wherein animals were forced to run using negative
reinforcement. Rats in the exercise group ran on a treadmill equipped with an electrical
grid on the posterior portion. Noncompliance with the running would cause the tail or
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hind limb/s to make contact with an electrical grid causing a stimulus strong enough to
elicit an aversive reaction. While this aversive stimulus served as a negative reinforcer
for running noncompliance, it may have created a stressful environment for the animal
thereby potentially negating the positive treatment effect of exercise. Subsequently,
the possibility that stress may have negatively affected the neuroprotective effect of
exercise cannot be ruled out. A future study using an exercise modality without an
aversive stimulus or reinforcer would be necessary to clear up this issue. In addition, a
brief preconditioning trial of the treadmill exercise prior to the surgery may have
familiarized the animals with the treadmill and the associated aversive stimulus; this
may have decreased the stress experienced during the first few days of treadmill use
post injection when the rats were being conditioned to run.

CONCLUSIONS
The results of the present study demonstrated that treadmill training in a 6OHDA model of PD did not mitigate the behavioral deficits of hemiparkinsonism. This
study casts doubt on the previously held assertion that exercise ameliorates behavioral
deficits in rodent models of PD. These results are in contrast to several studies that had
found a robust treatment effect of exercise after induction of the disease; however, the
present findings are consistent with at least one other study. Discrepancies in the
results of the present study and those with a positive treatment effects may by
accounted for by differences in the type of training and assessment. It is also possible
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that stress-inducing electrical shocks for running noncompliance during treadmill
training may have negated the benefit afforded by exercise.
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CHAPTER 3
Forced exercise before induction of 6-OHDA-mediated nigrostriatal insult:
neuroprotection in an adult hemiparkinsonian rat model
Abstract: Recent research has shown that rats preconditioned with exercise are less
susceptible to toxin-induced PD in terms of Parkinsonian behavioral symptoms and
underlying levels of dopamine and its metabolites. While these promising findings
suggest that exercise might protect against dopaminergic attrition, there have been few
studies that have utilized a forced exercise regimen prior to the induction of 6hydroxydopamine (6-OHDA) hemiparkinsonism in rats. Therefore, the purpose of this
study was to explore the role of forced exercise before the induction of PD with the
intent of supporting these previous findings. Prior to the neurotoxin-induced PD,
animals were randomized into two 4-week experimental groups, an exercise group and
a non-exercise control group. After participation in the experimental conditions,
hemiparkinsonism was induced using a unilateral injection of 6-hydroxydopamine.
Parkinsonian behavioral tests (i.e., apomorphine rotations, forelimb placement
asymmetry, exploratory rearing) did not show any significant differences between the
two groups. These results are in contrast to the literature and suggest that the notion
that exercise is neuroprotective may be premature. Further research is warranted.
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INTRODUCTION
Exercise early in life may be protective against the development of Parkinson’s
disease (PD). Chen et al, in a study of 125,828 men and women, found that greater
baseline physical activity was associated with a lower risk of PD and that strenuous
exercise in early adult life was inversely related to PD in men (Chen et al., 2005).
Strenuous exercise resulted in a 60% lower PD risk in men. In another very large
epidemiologic study (i.e., 50,002 men who attended Harvard University or Penn
University), Sasco et al (1992) found that moderate or heavy sports participation in
college was associated with a reduced risk of PD suggesting a slight neuroprotective
effect (Sasco et al., 1992). In a case control study by Tsai et al (2002), they found that
early exposure to well water drinking and head trauma may trigger and expedite the
appearance of PD features, but such acceleration may be prevented through regular
exercise (Tsai et al., 2002). Taken together, these studies offer indirect evidence that
exercise may somehow afford protection to the brain in areas relevant to PD.
In rodent models of PD, exercise or physical activity has also been shown to be
neuroprotective prior to the induction of PD. Cohen et al (2003) found that forced use
prior to experimentally induced hemiparkinsonism with 6-hydroxydopamine (6-OHDA)
in rats prevented the development of Parkinsonian motor deficits and lessened the loss
of striatal dopamine (Cohen et al., 2003). Adult mice preconditioned with exercise (i.e.,
free access to a running wheel) were found to exhibit outcomes consistent with
neuroprotection of the nigrostriatal system (i.e., dopamine transporters) against MPTPinduced Parkinsonism (Faherty et al., 2005). In addition, rats forced to be inactive (i.e.,
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no exercise) prior to a mild dose of 6-OHDA, which would not typically result in
behavioral asymmetries, actually caused profound, long-term behavioral asymmetry
and an exacerbation of the dopaminergic loss from an anticipated 20% loss to 60% loss
(Tillerson et al., 2002b). In essence, this study suggests the existence of a dose
dependent relationship of physical activity and disease severity prior to PD induction.
That is, exercise protects against the disease, whereas, inactivity makes one more
susceptible or vulnerable. Anstrom et al (2007) demonstrated that repetitive vibrissaeelicited forelimb placing, which is a sensorimotor exercise modality that is similar to a
forced exercise protocol, before 6-OHDA injection also provided a therapeutic
behavioral benefit to animals in terms of behavioral performance and sparing of
substantia nigra tyrosine hydroxylase immunoreactivity (Anstrom et al., 2007). Metz et
al (2004) also found a positive neuroprotective effect to the motor cortex due to a
preconditioning of a skilled reaching task prior to unilateral 6-OHDA-injection (Metz et
al., 2004). Taken together, these studies suggest, much like the human epidemiologic
studies, that exercise or physical activity prior to neurotoxic 6-OHDA insult may provide
neuroprotective benefit in terms of behavioral performance and underlying disease
processes.
Promising results from the human epidemiologic and rodent PD neuroprotection
studies warrant further investigation to determine if preconditioning of exercise can
protect the PD brain in terms of motor behavior. Several research groups have found
exercise to be neuroprotective in other rodent disease models, like stroke and ischemia
(Ang et al., 2003; Cechetti et al., 2008; Ding et al., 2004; Liebelt et al., 2010). The
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purpose, therefore, was to explore the role of forced exercise prior to the onset of 6OHDA hemiparkinsonism in adult rats. Parkinsonian behavioral tests were conducted to
determine if forced exercise mitigated behavioral deficits.

METHODS
Overall study design
Twenty-six male Long Evans rats (Charles River Laboratories, California, USA)
were used in this study. These rats were housed individually under standard laboratory
conditions with a 12 hour light/dark cycle and were fed ad libitum throughout the
duration of the study. The planning and execution of the experiments in this study were
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use
Committee and were consistent with the National Institute of Health Guide for the Care
and Use of Laboratory Animals. All rats were initially randomized into one of two 4week treatment groups: forced exercise and non-exercise control (Table 11; Figure 8).
Immediately after completely the 4-week treatment protocol, hemiparkinsonism was
induced using an injection of the dopaminergic neurotoxin, 6-hyrdroxydopamine
hydrochloride (6-OHDA). Approximately 6-8 days after the neurotoxin injection, rats
were tested for motor asymmetry using three behavioral tests: apomorphine rotations,
forelimb placement asymmetry, and exploratory rearing.
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Table 11. Weight of rats at initial randomization and at 6-OHDA-induced
hemiparkinsonism.

Weight at
randomization
Weight at
6-OHDA injection

Run status

N

Mean

Runner
Non-runner
Runner
Non-runner

12
8
13
10

392.1
420.9
436.0
471.6

Std.
Deviation
30.8
31.5
38.6
19.3

Std.
Error
8.9
11.1
10.7
6.1

P
value
.057
.015

Figure 8. Basic overall study design.
26 male
Long Evans rats
1 week acclimatization

Random assignment

13 rats: Exercise group (EG)
4 weeks of exercise

13 rats: Control group (CG)
4 weeks of no exercise

6-OHDA injection

(3 died during surgery, I
EG rat and 2 CG rats)

1 week period to allow parkinsonian symptoms to develop

Behavioral tests:
• Apomorphine rotations
• Forelimb placement asymmetry
• Exploratory rearing

Exercise protocol
After a brief acclimatization period, all 26 rats were randomly assigned into one
of two 4-week experimental groups, a forced exercise group and a non-exercise control
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group. The non-exercise control group consisted of individually-housed rats with no
exercise equipment or access to exercise during the 4-week experimental period. The
forced exercise group consisted of forced running on a 3-lane rat running treadmill
during the light cycle (Exer 3/6 Treadmill from Columbus Instruments, Columbus, Ohio,
USA) for five days per week. Rats were run twice per day at a speed of 15 meters per
minute separated by at least one hour; each running bout lasted 15 minutes for a total
of 30 minutes per day (Tillerson et al., 2003). An electrical grid at the back end of the
treadmill served as an aversive stimulus if the rats came into contact with it due to poor
running or noncompliance with the exercise. The electrical grid had adjustable intensity
settings (i.e., 0.35 mA to 3.4 mA) at 200 millisecond pulses with an adjustable pulse
repetition rate of 1 to 4 per second. This was initially set high and then once the
running behavior was reasonably conditioned it was turned down.

Surgical procedures
After the 4-week experimental period, rats were anesthetized using an
intraperotoneal injection of 75 mg/kg Ketamine and 0.25mg/kg dexmedetomidine.
Desipramine hydrochloride (15 mg/kg) dissolved in saline was then injected
intraperotoneally to preserve noradrenergic neurons 30 minutes before injection of 6OHDA (Anstrom et al., 2007; O'Dell et al., 2007). This was done to mitigate attrition of
noradrenergic neurons as 6-OHDA may also be toxic to this class of cells.
Once the rats had achieved surgical anesthesia (i.e., deep and slow breathing,
unresponsive to paw-pinch), they were shaved and then immediately moved to the
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stereotactic frame (Kopf 900, David Kopf Instruments, Tujunga, California, USA) and
placed on the incisor bar. The head was then firmly positioned within the stereotactic
frame by means of ear bars which were placed in the ear canals. An eye ointment
(GenTeal 0.3% eye gel, USA) was then coated over the eyes. The cranium was then
swabbed with povidone-iodine topical antiseptic. A central incision was then made to
expose the skull and bregma after which a 1 mm burr hole was drilled through the
cranium to gain exposure to the cranial cavity at the following stereotactic coordinates:
3.3 mm posterior to bregma, 1.9 mm lateral, 8.2 mm ventral to skull surface (Paxinos &
Watson, 1998; Paxinos et al., 1985; Tillerson et al., 2003; Tillerson et al., 2002b). These
coordinates were used to guide the syringe into the right medial forebrain bundle which
contains dopaminergic neurons destined for the striatum. A 28-guage, 5 μl-microliter
syringe (Hamilton, Reno, Nevada, USA) was then used to deliver the neurotoxin to the
medial forebrain bundle. A total dose of 10 μg of 6-hydroxydopamine hydrobromide in
0.1% ascorbic acid (Sigma, St. Louis, USA) in 4 μl of 0.9% saline was injected at a rate of 1
μl/min for 4 minutes (Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003;
Tillerson et al., 2002b). After the four minute injection period, the syringe was carefully
removed from the burr hole. Following closure of the burr hole using bone wax, the
incision was closed with 5-6 sutures using standard simple interrupted pattern suturing
techniques.
Rats were kept warm using a warm heating pad and heating lamp throughout
the surgery and recovery. Atipamezole at 1 ml/kg (subcutaneous) was used as a
reversal agent for dexmedetomidine to bring the rats out of anesthesia. The rats were
49

injected with this drug immediately after removal from the stereotactic frame. The
sutured incision was swabbed again with povidone-iodine topical antiseptic to prevent
infection. The entire surgical procedure did not exceed 50 minutes. The rats were
observed in recovery for at least one hour. Once they became ambulatory on all four
limbs, they received postoperative analgesia using a 0.01mg/kg subcutaneous injection
of buprenorphine into the flank and were returned to their plastic housing units. They
received this same postoperative analgesia for the next three days. Three of the
twenty-six rats died after injection of the anesthesia medications
(ketamine/dexmedetomidine) and prior to injection of the neurotoxin 6-OHDA. The
reason for these deaths was not known but according to an on-site veterinarian it was
thought to be anesthesia related. There were no infections noted for the duration of
the study.

Parkinsonian behavioral testing
Approximately one week (6-8 days) after neurotoxin injection, rats were tested
to determine motor asymmetry as a result of the injection. The following three
behavioral tests were used to create a comprehensive assessment: apomorphineinduced rotations, forelimb placement asymmetry, and exploratory rearing.
Apomorphine rotations were evaluated by injecting 0.5 mg/kg apomorphine
hydrochloride subcutaneously in the dorsal right quadrant proximal to the pelvis (Sigma,
St. Louis, USA) dissolved in saline subcutaneously (Joghataie et al., 2004; Mabandla et
al., 2004; Roghani & Behzadi, 2001; Tillerson et al., 2002b). The number of times the
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animal rotated 360° in each direction over a 30-minute period was counted at a later
time using a videotaped recording taken from above the animal. Ipsilateral rotations
subtracted from the number of contralateral rotations resulted in a net number of
contralateral rotations (Poulton & Muir, 2005). Complete 360° rotations within 30
minutes in a round bowl have been shown to correlate with PD lesion severity (Hudson
et al., 1993; Metz & Whishaw, 2002). Thus, it was felt that apomorphine-induced
rotations would be a good indicator of dopaminergic cell loss.
Forelimb placement asymmetry was evaluated first by placing the animals in a
cylinder (22 cm wide by 26 cm high) and then initial forelimb touches to the walls of the
cylinder (i.e., impaired left forelimb first, unimpaired right forelimb first, simultaneous)
for each individual rearing episode were recorded (Moroz et al., 2004; O'Dell et al.,
2007; Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson
et al., 2002b). Rats were videotaped for 10 minutes from above and were then scored
using the following asymmetry ratio: (Right - Left)/(Right + Left + Both)(O'Dell et al.,
2007). Scores on the forelimb asymmetry ratio range from -1 to 1 with a high positive
ratio being consistent with greater use of the unimpaired forelimb over the impaired
forelimb. A negative asymmetry ratio would suggest greater use of the impaired
forelimb relative to the unimpaired forelimb. Thus, a high positive forelimb placement
asymmetry ratio would be consistent with a hemiparkinsonian lesion.
Exploratory rearing was evaluated by observing the 10 minute video tape of the
forelimb placement asymmetry test. The number of times that a rat reared on it hind
limbs during that 10 minute period was referred to as exploratory rearing. This has not
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been documented previously in the literature; however, it was felt that exploratory
rearing could be a potential new behavioral test for a common symptom in PD, a paucity
of movement (i.e., hypokinesia).

Data analysis
All analyses were conducted using SPSS version 19.0 (IBM SPSS, Chicago, Illinois,
USA). In order to determine if there was a difference between the forced exercise
group and the non-exercise control group, an independent samples t-test was
conducted for apomorphine rotations. Apomorphine rotations were only conducted
after the 6-OHDA injections. As forelimb placements and exploratory rearing were
measured at the start of the study (prior to the 4 week training period) and after at the
end of the study (after the 6-OHDA injections), two 2 (time: pre and post) by 2 (group:
runner and non-runner) mixed factorial ANOVAs were done, one for forelimb placement
asymmetry and one for exploratory rearing. In an exploratory secondary analysis, point
biserial correlations were analyzed for the immediate post-surgical observation (i.e.,
within 20 minutes) of right neck turning (yes or no) to the three other behavioral tests in
the study (Figure 9). This has not been previously documented in the literature. It was
felt that this immediate neck turning might correlate to the severity of the asymmetry
caused by the 6-OHDA injection and could potentially be a way of determining
immediate post-operative success in injecting this neurotoxin into the medial forebrain
bundle. An additional exploratory analysis was to compare the runners to the nonrunners in weight gain throughout the study. It was thought that because of the
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difference in activity level between the two groups there was a possibility that weight
from the start of the study to the time of surgery may have been differentially affected.
A 2 (time: pre and post) by 2 (group: runners and non-runners) mixed factorial ANOVA
with weight as the dependent variable was used to explore this possibility.

Figure 9. Profound right neck turning immediately (within 20 minutes) after surgery for
two of the rats.

RESULTS
Parkinsonian behavioral tests
There was a statistically significant difference between the runners and nonrunners on apomorphine rotations, t(20) = 3.094, P = 0.006. Animals that had run prior
to the 6-OHDA lesion rotated significantly more than the non-runners had (Table 12,
Figure 10).
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Table 12. Descriptive statistics of runners versus non-runners on apomorphine
rotations.

Apomorphine
rotations

Run status

N

Mean

Runners
Non-runners

12
10

306.5
139.0

Std.
Deviation
115.772
138.320

Std. Error
Mean
33.421
43.741

Figure 10. Apomorphine rotation box plot of runners versus non-runners.

Figure 10. Boxplot with medians, lower and upper quartiles, and smallest and largest
observations of runners and non-runners on the number of apomorphine-induced
contralateral rotations during a 30-minute testing period after 6-OHDA lesioning.
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There was not a statistically significant interaction between group and time for
forelimb placement asymmetry, F(1,16) = 0.680, P = 0.422 (ηp2 = 0.041, power = 0.121;
Table 13). The main effect of group was not significant (P = 0.639); however, the main
effect for time was significant (P < 0.001). Before the 4-week intervention, the rats were
fairly symmetrical in forelimb arm use (runners = -0.02; non-runners = -0.01; Figure 11).
One week after the 6-OHDA surgery, they were both fairly asymmetrical in their
forelimb use with a preference for wall touches using the unimpaired forelimb
regardless of treatment group (runners = 0.670; non-runners = 0.574; Figure 11).

Table 13. Descriptive statistics for forelimb placement asymmetry at the pre and post
assessments.

Runners
Non-runners

time

Mean

Pre
Post
Pre
Post

-.020
.670
-.005
.574

Std.
Deviation
.128
.230
.155
.355
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Std. Error
.040
.080
.056
.112

95% Confidence Interval
Lower Bound
Upper Bound
-.103
.064
.502
.839
-.123
.114
.335
.812

Figure 11. Forelimb placement asymmetry at the pre and post measurement times.

Forelimb placement asymmetry

1.200

Runners

Non-runners

1.000
0.800
0.600
0.400
0.200
0.000
-0.200
-0.400

Runners
Non-runners

Pre
-0.020
-0.005

Post
0.670
0.574

Figure 11. Means and standard deviations of the forelimb placement asymmetry ratio
during a 10-minute period for runners and non-runners before and after
implementation of the 4-week experimental treatment.

There was not a statistically significant interaction between group and time for
exploratory rearing, F(1,16) = .3.824, P = 0.068 (ηp2 = 0.193, power = 0.452; Table 14;
Figure 12). The main effect for group was not significant, p=.914; however, there was a
statistically significant main effect for time with more exploratory rearing at the pre
measurement (mean rears = 22.4, SE = 1.6) than the post measurement (mean rears =
13.1, SE = 1.5), regardless of group, P < 0.001.
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Table 14. Descriptive statistics for exploratory rearing at the pre and post assessments.

Runners
Non-runners

time

Mean

Std.
Deviation

Pre
Post
Pre
Post

23.8
11.4
21.0
14.8

7.1
4.2
4.4
8.7

Std.
Error
1.9
1.7
2.6
2.4

95% Confidence Interval
Lower
Upper
Bound
Bound
19.9
27.8
7.8
15.1
15.4
26.6
9.7
20.0

Figure 12. Graph of exploratory rearing at the pre and post measurement times.

Runners

Non-runners

35
30
25
20
15
10
5
0
Pre

Post

Figure 12. Means and standard deviations of the number of exploratory rearing
episodes during a 10-minute testing period for runners and non-runners before and
after 4 weeks of treatment.
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In the secondary exploratory analysis of the correlation between the other outcome
variables and the immediate observation of right neck turning in the first 20 minutes
after surgery, there were several moderate to high correlations (Table 15). Of note, the
right neck turn after surgery was strongly correlated with apomorphine rotations (r =
0.734) and exploratory rearing (P = -0.749).

Table 15. Correlations of immediate right neck turning after surgery to the three
behavioral tests.

Right neck turn after surgery
Apomorphine rotations
Forelimb asymmetry
Exploratory rearing

Right neck
turn after
surgery
1

Apomorphine
rotations
.734**
1

Forelimb
asymmetry

Exploratory
rearing

.534*
.331
1

-.749**
-.589*
-.511*
1

** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)

In the secondary analysis of weight gain throughout the study, there was no
significant interaction, which suggests that the running condition did not differentially
affect weight gain, F(1,18) = 0.505, P = 0.486 (ηp2 = 0.027, power = 0.103; Table 16;
Figure 13). As expected, there was weight gain throughout the study for both groups, P
< 0.001, from the pre measurement (weight = 406.5 grams, SE = 7.1, 95% CI: 391.6 –
421.4) to the post measurement (weight = 455.1 grams, SE = 7.8, 95% CI: 438.7 – 471.4).
There was also a main effect for group, P = 0.022, with the running rats weighing less
(weight = 414.0, SE = 8.4, 95% CI: 396.3 – 431.8) than the sedentary control rats (weight
= 447.5, SE = 10.3, 95% CI: 425.8 – 469.2).
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Table 16. Descriptive statistics for secondary analysis of weight gain throughout the
study.

Runners
Non-runners

Time

Mean

Std.
Deviation

Pre
Post
Pre
Post

392.1
436.0
420.9
474.1

30.8
40.3
31.5
20.9

Std.
Error
9.0
9.8
11.0
12.0

95% Confidence Interval
Lower
Upper Bound
Bound
373.3
410.9
415.3
456.7
397.8
443.9
448.8
499.4

Figure 13. Trajectory of weight gain over time for the runners and non-runners.

Runners

Non-runners

Weight in grams

500
450
400
350
300
Pre

Post

Figure 13. Means and standard deviations of the rats weighted in grams for runners and
non-runners before and after 4 weeks of treatment.
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DISCUSSION
Forced exercise prior to the onset of 6-OHDA-induced hemiparkinsonism in adult
rats did not mitigate behavioral deficits. Thus, rats who engaged in a regular forced
running program were not protected from the neurotoxin 6-OHDA more than the
sedentary non-runners in any of the behavioral tests. In fact, it could be argued, based
on the results of the apomorphine rotations, that non-runners were perhaps more
protected than forced runners; however, taken together, these results clearly cast
doubt on previous work that has shown a neuroprotective effect on PD (Cohen et al.,
2003; Faherty et al., 2005; Metz et al., 2004; Tillerson et al., 2002b). Based solely on the
results of the present study, the most logical conclusion is that a preconditioning of
exercise is not neuroprotective; nevertheless, in context of the many studies that have
demonstrated neuroprotection using this same model, the results of this study warrant
a closer look at the methodology and design of this study’s exercise parameters and
how they compare to the literature.
Neuroprotection in a PD model due to a preconditioning of exercise was first
documented by Cohen et al (2003) and Tillerson et al (2002) who found that forced
nonuse (i.e., sedentary behavior) prior to 6-OHDA lesioning potentiated behavioral
asymmetries (Cohen et al., 2003; Tillerson et al., 2002b). In the Cohen et al (2003)
study, which most closely approximates the present study in design, it was found that
forced reliance on a forelimb prior to contralateral injection of 6-OHDA prevented
behavioral asymmetries. The forced reliance in the Cohen et al (2003) study, which has
been equated to exercise, lasted for only 7 days prior to 6-OHDA lesioning and was
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executed by casting the unimpaired forelimb in a retracted position to immobilize it,
thereby forcing the animal to use the impaired forelimb for mobility, grooming, eating
and all other tasks. The dosing of this forced “exercise” was considerably more than the
30 minutes per day for 5 days per week of forced treadmill running even when you
consider that the length of treatment in the present study was 4 weeks. Using a
different PD model (i.e., mouse model using 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP)), Faherty et al (2005) used free access to a running wheel for
several months (Faherty et al., 2005). In the two studies that most closely resembled
the present study, the dosing of exercise was considerably higher. While the results of
the present study suggest that preconditioning with exercise may not be
neuroprotective, the lack of a positive treatment effect may be explained by the low
dose of the exercise. In light of this, further research using a more rigorous
precondition of exercise is warranted.
Another possibility for the lack of positive treatment effect from the
preconditioning of exercise is deleterious stress. Smith et al (2002) hypothesized that
stress might be a key factor in the loss of dopaminergic neurons that underlie the
pathology of PD (Smith et al., 2002). They based this hypothesis on the following lines
of evidence: 1. stress has been shown to increase PD symptoms in humans; and, 2.
animal PD models have shown that stress is deleterious and cancels out the positive
treatment effect of exercise. Smith et al (2002) reported that animals subjected to
restraint stress and then immediately injected with 6-OHDA demonstrated significantly
greater behavioral impairments than animals that were just injected with 6-OHDA. They
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argue that this stress may actually increase the vulnerability of dopaminergic neurons to
subsequent insult, a phenomenon that Sapolsky termed “neuroendangerment”
(Sapolsky, 1992). Howells et al (2005) provided validity to this notion by demonstrating
that mild stressors were able to cancel out the neuroprotective effects of voluntary
exercise in 6-OHDA-lesioned animals (Howells et al., 2005). In addition, others have
demonstrated that stress increases motor impairments in the 6-OHDA model (Snyder et
al., 1985). In the present study, rats were exposed to a forced exercise regimen during
the light cycle which is not a not a typical time for increased activity and is, therefore, a
potential mild stressor. In addition and perhaps more stressful, the rats were forced to
run on a treadmill with an aversive electrical stimulus. When the rats would stop
running or were non-compliant with running they would receive an unpleasant electrical
shock. While most rats learned quickly, the occasional slowing on the treadmill was a
quick reminder that a painful shock was ever present. This may have created a stressful
milieu and may have negated the neuroprotective effect of exercise. A more
sophisticated research design would be necessary to verify this assertion.
In the secondary analysis on weight gain, all of the rats increased weight from
the start of the study to just before the 6-OHDA lesioning. This suggests that the forced
running did not differentially slow weight gain compared to the sedentary non-runner
group. Since the rats were fed ad libitum, the logical supposition is that the increase in
physical activity was met by a concomitant increase in food intake. However, the main
effect for group does indicate that the forced runners did not weigh as much as the nonrunners. However, closer inspection shows that the runners started out lighter and
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finished lighter than the non-runners; the trajectory of their weight gain was the same
as the non-runners so it is not likely that differential weight gain may have played a role
in the motor impairment (Figure 19). In addition, because the weights of the animals
were all within a relatively tight range, the stereotactic coordinates for the 6-OHDA
injections were the same and not likely to be affected by differences in animal or head
size.
It was noted that during recovery shortly after the 6-OHDA injections (before the
rats had achieved full consciousness) that many of the rats would start to turn their neck
sharply to the right (Figure 15). Because this was an unusual post-surgical presentation
for an animal and because it was ipsilateral to the 6-OHDA lesion, the presence of this
right sidebending was recorded for further analysis as a potential indicator of lesion
severity. The results of this analysis indicate that this immediate right neck turning was,
in fact, related to the severity of the lesion with significant point biserial correlations for
all three of the behavioral tests with the highest correlations for apomorphine rotations
and exploratory rearing (Table 15). Based on these results, it appears that the
immediate right neck turning is an early indicator of the 6-OHDA injection success. In
light of these findings, further assessment of right neck turning after 6-OHDA injection
as a possible immediate behavioral indicator of successful placement into the medial
forebrain bundle is warranted.
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CONCLUSION
A preconditioning of regular forced exercise did not protect 6-OHDA-induced
hemiparkinsonian behavioral asymmetry prior to the onset of the lesion in adult rats.
These results are not consistent with previous data that has shown a neuroprotective
effect of forced exercise on subsequent neurotoxic insult and cast doubt about the
validity of these previous findings. In light of the present results, further research is
warranted.
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CHAPTER 4
A comparison of voluntary and forced exercise in driving neuroprotection of
nigrostriatal pathways in a juvenile hemiparkinsonian rat model

Abstract: Several studies have found a neuroprotective effect of forced exercise in
rodent Parkinson’s disease models; however, the evidence for the protective effect of
voluntary exercise is mixed. Most of these studies have initiated the exercise after
toxin-induced hemiparkinsonism. Few studies have investigated the role of a
preconditioning of exercise prior to neurotoxic insult. Therefore, the purpose of this
study was to explore the neuroprotective effect of regular forced and voluntary exercise
in recently weaned rat pups prior to an adult hemiparkinsonian lesion. Recently
weaned rat pups were randomized into four 6-week experimental groups: forced
exercise, voluntary exercise, control, and a sham surgery control. After participation in
a 6-week experimental condition, hemiparkinsonism was induced using a unilateral
injection of 6-hydroxydopamine (6-OHDA). Parkinsonian behavioral tests (i.e.,
apomorphine rotations, forelimb placement asymmetry, exploratory rearing)
demonstrated significant motor asymmetry for all three 6-OHDA group; however, there
were no significant differences among them. The sham control rats did not show motor
impairment consistent with nigrostriatal motor deficits. Neither a preconditioning of
forced nor voluntary exercise was neuroprotective of a future 6-OHDA lesion. These
results are in contrast the literature and challenge the validity of these previous studies.
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INTRODUCTION
Exercise produces a plethora of benefits in those who have been diagnosed with
Parkinson’s disease (PD) (Crizzle & Newhouse, 2006; Goodwin et al., 2008; M. A. Hirsch
& Farley, 2009). In fact, many national and international panels on the topic have
recommended the use of exercise to improve outcomes, activities of daily living and
motor performance in those with PD (Horstink et al., 2006; Keus et al., 2007;
Suchowersky et al., 2006b). Others have suggested the type of exercise is an important
prescriptive consideration in PD (Ridgel et al., 2009). While these studies collectively
suggest that functional outcomes are indeed improved with general exercise, they add
little knowledge as to how exercise and different exercise parameters influence the
underlying disease processes of PD. For this reason, studies using comparative-control
designs with animal models of PD are needed to explore these relationships.
In animal models, there are two different exercise modalities, forced exercise
and voluntary exercise. While several studies have found a neuroprotective effect on
PD with forced exercise (Cohen et al., 2003; Tillerson et al., 2002a, 2003; Tillerson et al.,
2001), the results with voluntary exercise are not as well developed. O’Dell et al (2007)
found that voluntary wheel running facilitated motor recovery following toxin-induced
PD but does so without sparing of dopamine terminals (O'Dell et al., 2007). Mabandla
et al (2004) found that voluntary running using the same PD model did prevent
apomorphine-induced contralateral rotations suggesting a sparing of dopaminergic
neurons (Mabandla et al., 2004). Much like forced exercise, these latter two studies
suggest that voluntary exercise may also offer some benefit in rodent models of PD.
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One of the key differences between these two exercise modalities is that
voluntary exercise allows the animal freedom to choose the timing and dosage of the
exercise, whereas forced exercise removes this aspect and usually relies on an aversive
stimulus to condition the behavior. In the case of rat forced exercise models, this
usually means an electrical grid on the back of a rodent treadmill that administers an
electrical shock should the rat slow down or stop running. Unpleasant “encounters”
with the electrical grid due to running noncompliance is what conditions running
behavior. While this aversive stimulus is effective at conditioning running behavior, it
can create a stressful atmosphere for the animal. Voluntary running occurs when the
animal decides, usually in the dark cycle; whereas, forced running usually occurs during
the light cycle for researcher convenience. The light cycle is typically a time of less
activity for the animal and so it is plausible that this may add to the already stressful
environment of forced running. Importantly, stress has received traction in the
literature as a key factor in the loss of dopaminergic neurons that underlies PD (Smith et
al., 2002). In support of this notion, Howells et al (2005) demonstrated that even mildly
stressful conditions can negate the neuroprotective effect of exercise in a rat model of
PD (Howells et al., 2005).
A recent review from the literature (Ang & Gomez-Pinilla, 2007) suggests that
forced exercise and voluntary exercise have different effects on brain neurochemistry
and behavior. Leasure and Jones (2008) found that rats in a forced exercise condition
ran about the same distance as rats that voluntarily exercised (Leasure & Jones, 2008).
However, they report that voluntary exercise rats ran faster and for less total time than
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rats that were forced. Additionally, they found that rats in the forced exercise condition
exhibited more anxiety-like behaviors compared to the voluntary exercisers despite the
fact that there was no difference in corticosterone between the two groups. Leasure
and Jones (2008) further suggest that it is imperative that neural and behavioral effects
of different forms of exercise using the similar parameters need to be addressed in
greater detail scientifically (Leasure & Jones, 2008).
Almost all of the aforementioned studies on the effect of exercise
neuroprotection have administered the experimental exercise condition after the onset
of toxin-induced PD. Some would argue that this is not technically neuroprotection but
rather neuroplasticity of undamaged dopaminergic neurons. While the convention is to
use the term “neuroprotection,” it is not technically correct; neuroprotection is
technically something that protects nerves from future insult, not a “treatment”
administered after the onset of the disease. Few studies have used a true
“neuroprotection” design, wherein an exercise program was administered to rats before
a 6-OHDA-induced PD (Cohen et al., 2003; Mabandla et al., 2004; O'Dell et al., 2007).
While the designs of these studies certainly makes sense from a neuroprotective
perspective, they may not capture the true neuroprotective effect of exercise
throughout the life of the animal as they were all administered to adult rats. For this
reason, the purpose of this study was to explore the neuroprotective effect in terms of
parkinsonian behavioral signs of regular forced and voluntary exercise in recently
weaned rat pups until they received an adult, neurotoxin-induced PD lesion.
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METHODS
Overall study design
Thirty-eight male recently weaned Long Evans rats (Charles River Laboratories,
California, USA) were randomized into one of four different experimental groups prior
to induction of hemiparkinsonism using an injection of the dopaminergic neurotoxin, 6hydroxydopamine hydrochloride (6-OHDA). The four experimental groups each lasted 6
weeks and consisted of the following: forced exercise, voluntary exercise, control, and
sham surgery control (Figure 14). The original randomization allocation was 10 rats to
each of the experimental groups and 6 to the sham group. Because two additional rats
were delivered by Charles River Laboratories, randomization was changed to a stratified
randomization plan wherein the two additional rats were allocated to the forced
exercise group since attrition from non-compliance with forced running has been a
concern in previous studies conducted by this investigator; therefore, it was felt that a
few extra animals in the forced running group would help in the case of drop out from
running non-compliance. After the 6-week experimental treatment and 6-8 days
following 6-OHDA lesioning, neuroprotection was tested using three different motor
behavioral tests (forelimb asymmetry, apomorphine rotations, exploratory rearing).
Rats were housed individually, fed ad libitum, and housed under standard
laboratory conditions with a 12 hour light/dark cycle. All experimental conditions were
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use
Committee and were consistent with the National Institute of Health Guide for the Care
and Use of Laboratory Animals.
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Figure 14. Overall study design.
38 male – 75-100
gram Long-Evans
rats

Group 1:
Forced exercise
12 rats

Group 2:
Voluntary exercise
10 rats

Group 3:
Control
10 rats

Group 4:
Sham
6 rats

6-OHDA surgery

•
•
•

Motor behavior tests:
Forelimb placing asymmetry
Apomorphine rotations
Forelimb exploratory rearing

Experimental conditions
Group 1 (forced exercise) was a 6-week regimen (5 days per week with 2 bouts
of 15 minute periods per day starting at a speed of 8 m/min (Kuo et al., 2010) for two
weeks and ultimately progressing to 15 meters/minute for the last 4 weeks (Tillerson et
al., 2003) using a rodent treadmill with three running lanes (Exer 3/6 Treadmill,
Columbus Instruments, USA); generally, three rats ran concurrently. The treadmill was
equipped with an electrical grid at the back end of the belt that would elicit an aversive
electrical stimulation upon contact with the tail or hind limbs of rats that had slowed or
were noncompliant with running. Once rats were conditioned to the aversive electrical
stimulus, the intensity of the stimulus was turned down so that any incidental contacts
with the tail would not result in a strong electrical shock. In most cases, the stimulus
intensity was turned down to imperceptible levels.
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Group 2 (voluntary exercise) was a 6-week regimen of voluntary exercise. These
rats were housed singly in a plastic housing container that had an attached running
wheel with a revolution counter. Running wheel revolutions were recorded daily to
determine the overall dosing of exercise. Group 3 (no exercise) was the non-exercise
control group. These control rats were housed singly for six weeks with no running
wheel and no other opportunities to exercise or run. Group 4 (sham) was essentially the
same as Group 3 in terms of housing and exercise; however, sham rats received a saline
injection instead of 6-OHDA during the stereotactic surgery. All other surgical
procedures for the sham group were identical to the other three groups.

Surgical procedures
After the 6-week experimental treatment, all rats had a neurosurgerical injection
into their nigrostriatal fibers. The first three groups (except Group 4) had a 6-OHDA
neurotoxin injection into the right medial forebrain bundle. Animals were anesthetized
using an intraperotoneal injection of 75 mg/kg Ketamine and 0.25mg/kg
dexmedetomidine. After the animal had achieved surgical anesthesia, they were shaved
and then moved to the stereotactic frame (Kopf 900, David Kopf Instruments, Tujunga,
California, USA). The head was placed into the frame using ear bars which were placed
into the ear canals. Once the head was symmetrically placed in the frame, the incisor
bar was placed and the nose clamp was tightened. Eye ointment (GenTeal 0.3% eye gel,
USA) was placed on the eyes and the incision site on the head was generously swabbed
with povidone-iodine topical antiseptic. A heating pad was placed under the rat to keep
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in warm during the procedure. Following a longitudinal incision to expose the skull and
bregma, a small 1-mm burr hole was drilled through the cranium with a mounted dental
drill to gain exposure to the cranial cavity using the following coordinates: 3.3 mm
posterior to bregma, 1.9 mm lateral to the midline (Paxinos & Watson, 1998; Paxinos et
al., 1985; Tillerson et al., 2003; Tillerson et al., 2002b). A 28-guage, 5 μl-microliter
syringe (Hamilton, Reno, Nevada, USA) was then plunged into the burr hole 8.2 mm
ventral to the skull surface and 10μg of 6-hydroxydopamine hydrobromide (10 μg/4μl
0.155 M sterile NaCl containing 0.2 μg/μl ascorbic acid; Sigma, St. Louis, MO)(Howells et
al., 2005; Mabandla et al., 2004) in 4 μl of 0.9% saline was injected at a rate of 1 μl/min
for 4 minutes (Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003; Tillerson
et al., 2002b) into the right medial forebrain bundle which contains the dopaminergic
nigrostriatal fibers.
The burr hole was closed using bone wax and the incision was sutured with 5-6
sutures using simple interrupted suture patterning. The incision was swabbed in
povidone-iodine antiseptic once more to prevent postsurgical wound infection. The
entire neurosurgical procedure did not exceed 45 minutes. After removal from the
stereotactic frame, rats were brought out of surgical anesthesia using atipamezole, a
dexmedetomidine reversal agent, at 1 ml/kg (subcutaneous). After approximately 10-20
minutes, the rats were out of anesthesia and mobile on all fours. However, they were
observed for another hour before they were moved back to their plastic housing units.
To manage postoperative pain, rats were then injected with 0.01 mg/kg (subcutaneous)
buprenorphine into the flank shortly after ambulatory on all fours. They received this
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same injection for the next three days. There were no surgery-related animal deaths or
any postsurgical infections in any of the animals in this study.

Motor behavior tests
After 6-8 days post-6-OHDA injection, all of the animals were tested for the
severity of the disease (apomorphine rotations), the severity of their motor asymmetry
(forelimb placement asymmetry), and the extent of their hypokinesia or paucity of
movement (exploratory rearing). During this 6-8 day period, the rats in the two exercise
groups continued with their same exercise regimen. The rats in the forced exercise
condition began treadmill exercise within 24 hours of the hours of the lesion but were
run only once for the first two days after the lesion. For the next 4-6 days, they
returned to their twice per day exercise protocol. The voluntary exercise rats were
returned to their plastic housing units and were given free access to the running wheels.
Apomorphine rotations. Apomorphine rotations were evaluated by a
subcutaneous injection of 0.5 mg/kg apomorphine hydrochloride (Sigma, St. Louis, USA)
dissolved in saline in the dorsal right quadrant proximal to the pelvis (Joghataie et al.,
2004; Mabandla et al., 2004; Roghani & Behzadi, 2001; Tillerson et al., 2002b).
Apomorphine rotations are thought to be due to 6-OHDA-induced denervation of the
right medial forebrain bundle; this causes the dopamine receptors in the right striatum
of the basal ganglia to become hypersensitive due to the paucity of dopamine relative to
the contralateral side. Apomorphine stimulates receptors on both sides (i.e., the
affected and unaffected basal ganglia) but because the receptors on the right (affected)
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are hypersensitive the outcome is a relative increase of right striatal activity compared
to the contralateral side. Since the right striatum of the basal ganglia influences motor
behavior on the contralateral side (left side), this causes a rapid, repetitive turning of
the body away or contralateral (i.e., to the left) from the lesioned side. The number of
times the animal rotated 360° in each direction over a 30-minute period was counted at
a later time using a videotaped recording that was taken from above the animal during
the 30-minute period. Ipsilateral rotations subtracted from the number of contralateral
rotations resulted in a net number of contralateral rotations (Poulton & Muir, 2005).
Complete 360° rotations within 30 minutes in a round bowl have been shown to
correlate with PD lesion severity (Hudson et al., 1993; Metz & Whishaw, 2002). In
addition, it has been reported that a rat which turns more than 200 times in a 30 minute
period has had a 95% depletion of striatal dopamine (Schwarting & Huston, 1996).
Since apomorphine rotations are directly related to the severity of the dopaminergic
attrition, this test has been recognized as a surrogate for severity of the nigrostriatal
neurotoxin-induced damage. It has been used as a motor outcome measure in nearly
every exercise study that has used the 6-OHDA PD model.
Forelimb placement asymmetry. Forelimb asymmetry was evaluated first by placing
the animals in a plastic cylinder (22cm wide by 26 cm high) for 10 minutes and then by
videotaping from above their behavior over that time. As the animal would rear for
exploration, the number of initial forelimb touches to the walls of the cylinder (i.e.,
impaired left forelimb first, unimpaired right forelimb first, simultaneous) for each
individual exploratory rearing episode was recorded (Moroz et al., 2004; O'Dell et al.,
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2007; Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson
et al., 2002b). The wall touches were recorded and the asymmetry ratio was calculated
using the following: (Right-Left)/(Right+Left+Both)(O'Dell et al., 2007). Scores on the
forelimb asymmetry ratio range from -1 to 1 with a high positive indicative of
asymmetry favoring the unimpaired forelimb. A negative asymmetry ratio would be
indicative of greater left or impaired forelimb usage. Thus, a high positive forelimb
placement asymmetry ratio (i.e., greater right, unimpaired forelimb use) would be
consistent with a right 6-OHDA-induced hemiparkinsonian lesion.
Exploratory rearing episodes. Each episode of exploratory rearing was counted over
the 10 minute videotaped session that was used for forelimb placement asymmetry.
This has not been documented previously in the literature but significant correlations
with the other behavioral tests in Chapter 3 suggest that it may offer some value in
motor behavior; it was felt that exploratory rearing was a logical test for a common
symptom in PD, hypokinesia (i.e., paucity of movement).

Data analysis
All analyses were conducted using SPSS version 19.0 (IBM SPSS, Chicago, Illinois,
USA). In order to determine if there was a difference among the four experimental
groups (forced exercise, voluntary exercise, control, and sham control), a one way
analysis of variance (ANOVA) was conducted for each of the three behavioral tests
(apomorphine rotations, forelimb placement asymmetry, and exploratory rearing) that
were conducted immediately after the 6-week treatment ended (Figure 14). When
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significant violations of assumptions occurred than non-parametric equivalents were
used in lieu. In an exploratory secondary analysis, spearman correlations were
conducted for the immediate post-surgical observation (i.e., within 20 minutes) of right
neck turning (0 = no neck turn, 1 = delayed and mild neck turn, 2 = delayed but profound
neck turn, 3 = early and severe neck turn) to the three other behavioral tests in the
study (Chapter 3; Figure 9). Significant correlations of this were found in study 2 of this
dissertation (Chapter 3; Table 15). As this has been the only line of evidence to suggest
that this immediate post-operative phenomenon may be related to 6-OHDA
nigrostriatal neurotoxic damage, this observation was again noted in this study for
exploratory analysis. Data in the present study were also analyzed using point biserial
correlations (similar to Chapter 3 results) to see if the correlations were in the same
range as Chapter 3 results; immediate post-surgical right neck turning was dichotomized
(1 = no or mild neck turn, 2 = profound neck turn) and reanalyzed using correlations
among the three behavioral tests with point biserial correlations. An additional
exploratory analysis was to compare the weight of the four groups during the
experimental treatment. It was thought that because of the difference in activity level
among the four groups there was a possibility that a significant difference in
weight/growth may have been a threat to internal validity as the stereotactic
coordinates would have been different for different size animals. This analysis was
conducted using an 8 (time: 7 preoperative measurements, 1 postoperative
measurement at the time of surgery) by 4 (group: forced, voluntary, control, sham)
mixed factorial ANOVA. The last exploratory analysis was a comparison between the
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two exercise groups on the dosing of exercise. This was done by comparing the average
daily distance ran in meters and comparing the preoperative treatment with the
postoperative treatment using a 2 (group: forced and voluntary) by 2 (time:
preoperative average and postoperative average) mixed factorial ANOVA.

RESULTS
Primary analyses
Because of a violation of homogeneity of variance (P = 0.05) coupled with
unequal group sizes, a Kruskal-Wallis non-parametric test was run for the apomorphine
data. There was a statistically significant difference among the medians of apomorphine
rotations, H(3) = 9.754, P = 0.021. Pairwise comparisons were run using the
nonparametric Mann-Whitney test. All three of the groups that had the 6-OHDA
injection (i.e., voluntary, forced, control) rotated significantly more than the one group
that had a saline injection (i.e., sham), Ps ≤ 0.018 (Table 17, Figure 15). There were no
differences in apomorphine rotations among the three groups that had the 6-OHDA
injection, Ps ≥ 0.111.
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Table 17. Apomorphine rotation descriptive statistics for the forced, voluntary, control
and sham groups.

Apomorphine
rotations

Forced
Voluntary
Control
Sham

N

Mean

Std.
Deviation

Std.
Error

12
9
10
6

131.3
75.0
90.6
-11.5

93.3
74.8
74.3
14.4

26.9
24.9
23.5
5.9

95% Confidence
Interval
Lower
Upper
Bound
Bound
72.07
190.60
17.50
132.50
37.44
143.76
-26.59
3.59

Figure 15. Boxplot of apomorphine rotations for the forced, voluntary, control and
sham groups.
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Figure 15. Means and standard deviations for the number of apomorphine-induced
contralateral rotations during a 30-minute testing period for runners and non-runners
before and after 4 weeks of experimental treatment.

There was a statistically significant difference among the means for the four
groups for forelimb placement asymmetry, F(3,37) = 8.509, P < 0.001. Tukey pairwise
comparisons revealed that the three groups that had the 6-OHDA injection had
significantly more forelimb asymmetry than the sham group, Ps ≤ 0.001 (Table 18,
Figure 16). The forelimb asymmetry was essentially the same for the three 6-OHDA
groups, Ps ≥ 0.909.

Table 18. Forelimb placement asymmetry descriptive statistics for the forced,
voluntary, control and sham groups.

Forelimb
placement
asymmetry

Forced
Voluntary
Control
Sham

N

Mean

Std.
Deviation

Std.
Error

12
10
10
6

-.703
-.793
-.776
-.057

.385
.194
.385
.084

.111
.061
.122
.034
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95% Confidence
Interval
Lower
Upper
Bound
Bound
-.9477
-.4586
-.9316
-.6536
-1.0514
-.5011
-.1447
.0305

Figure 16. Boxplot of forelimb placement asymmetry for the forced, voluntary, control
and sham groups.

Figure 16. Means and standard deviations for the forelimb placement asymmetry ratio
during a 10-minute testing period for runners and non-runners before and after 4 weeks
of experimental treatment.

The number of exploratory rears in a 10 minute period was not the same for all
four of the experimental groups, F(3,37) = 6.436, P = 0.001. The number of exploratory
rears was similar among the three groups that had the 6-OHDA injections, Ps ≥ 0.842;
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however, each of these three 6-OHDA injection groups had fewer rearing episodes than
the sham lesion group, Ps ≤ 0.008 (Table 19, Figure 17).

Table 19. Exploratory rearing descriptives for the forced, voluntary, control and sham
groups.

Exploratory
rearing

Forced
Voluntary
Control
Sham

N

Mean

Std.
Deviation

Std.
Error

12
10
10
6

23.2
18.7
20.0
45.0

13.9
13.2
9.9
13.1

4.0
4.2
3.1
5.4
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95% Confidence
Interval
Lower
Upper
Bound
Bound
14.3634
31.9699
9.2816
28.1184
12.8863
27.1137
31.2048
58.7952

Figure 17. Boxplot of exploratory rearing for the forced, voluntary, control and sham
groups.

Figure 17. Means and standard deviations of the number of exploratory rearing
episodes during a 10-minute testing period for runners and non-runners after 6 weeks
of the experimental conditions.

Secondary analyses
Significant Spearman correlations were observed for the immediate post-surgical
observation of right neck turning to the three other behavioral tests in the study (Table
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20). The values for the correlations among the three behavioral tests in Table 20 are
Spearman’s correlations. The point biserials of the dichotomized neck turning to the
behavioral tests were the following: apomorphine rotations (r = 0.480), forelimb
placement asymmetry (r = -0.357), and exploratory rearing (r = -0.479).

Table 20. Spearman correlations for right neck turn after surgery of the three
behavioral tests.
Right neck
turn after
surgery
1

Apomorphine
rotations
.492**
1

Right neck turn after surgery
Apomorphine rotations
Forelimb asymmetry
Exploratory rearing
** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)

Forelimb
asymmetry

Exploratory
rearing

-.363**
-.633**
1

-.363**
-.383*
.444**
1

The weight of the recently weaned rats increased significantly over the course of
the trial, p<.001; however, there was no difference in the rate of weight gain among the
four groups over time, F(21,238) = 1.810, P = 0.100, power = 0.682 (Table 21, Figure 18).
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Table 21. Weight gain for all of the rats over the course of the study.
time

Mean

Std. Deviation

Std. Error

Pre
1
2
3
4
5
6
Post

53.8
117.8
167.7
214.0
264.6
298.6
328.0
323.8

6.1
13.1
14.3
18.1
18.5
21.9
25.6
31.7

0.9
2.2
2.3
3.0
2.9
3.7
4.0
5.1
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95% Confidence Interval
Lower Bound Upper Bound
52.0
55.7
113.3
122.2
163.0
172.5
207.8
220.1
258.7
270.5
291.1
306.1
319.9
336.2
313.4
334.2

Figure 18. Weight gain for each of the four treatment groups over the duration of the
study.

Figure 18. Means and standard deviations of the weight in grams of the rats in the four
experimental conditions at each of the 6 weeks preceding the 6-OHDA lesion and one
week after the lesion.

In terms of the difference between the two exercise groups, voluntary and
forced, in the average number of meters ran per day, the voluntary group ran
significantly more than the forced group before and after the surgery, P < 0.001 (Figure
19).
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Figure 19. Average distance ran in meters for the 6 weeks pre surgery and the 1 week
post-surgery for the voluntary and forced exercise groups.

Average distance ran in meters/day

Voluntary

Forced

4500
4000
3500
3000
2500
2000
1500
1000
500
0

Pre

Post

Figure 19. Means and standard deviations of the average distance ran in meters in the
forced and voluntary exercise conditions in the 6 weeks before and the one week after
the 6-OHDA lesioning.
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Figure 20. Average daily distance in meters ran for each rat in the voluntary running
group.
8000.0
7000.0

Meters per day

6000.0
5000.0
4000.0
3000.0
2000.0
1000.0
0.0

1

2

3

4

5

6

7

8

9

10

Distance 1171.3 3021.4 4482.3 2804.8 2534.4 6909.0 5069.3 4849.6 2220.6 4238.4

Figure 20. Means of the distance ran in the 6 weeks of voluntary exercise for each of
the rats in the voluntary exercise group.
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Figure 21. Daily totals in running wheel clicks over the 6 weeks of voluntary running and
the one week after running.

Clicks on running wheel per day

90000
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Figure 21. Daily means of the distance ran for each of the rats in the voluntary running
group showing the increase in trajectory of running during the 6 weeks prior to 6-OHDA
lesioning.

DISCUSSION
While previous research has provided several lines of evidence that exercise in
rodent models of PD is neuroprotective, the results of the present study do not support
this notion. In addition, it has been demonstrated that neither forced nor voluntary
running affords neuroprotection in 6-OHDA-induced hemiparkinsonian rats. Despite the
novel design element of introducing the exercise shortly after weaning, which would be
akin to exercising throughout life, there was no evidence that exercise provided
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neuroprotection from 6-OHDA-induced behavioral asymmetry. These results are in
contrast to the body of literature on exercise neuroprotection in PD and cast doubt on
the validity of the notion that exercise is neuroprotective in PD.
Several human studies have shown that greater baseline exercise in early life is
associated with a lower risk of PD (Chen et al., 2005; Sasco et al., 1992; Tsai et al., 2002).
This exercise occurred before PD diagnosis and presumably before the pre-clinical phase
had begun. This was an important consideration in the casting of the design of the
present study. Namely, that implementation of a putative neuroprotective treatment
should happen before the onset of the disease rather than after the fact on while the
disease is in process. All of the previous work using a true neuroprotective design (i.e.,
exercise implemented before the neurotoxic lesion) had staged the implementation of
the exercise to rats who were physically mature adults. Since neurodevelopment is
most robust in young and adolescent brains, it was felt that an important
neuroprotective window of opportunity may have not been appropriately vetted
scientifically. Thus, in the present study, exercise was implemented shortly after
weaning and continued for 6 weeks, which would be well into the maturity of the
animal. From a design perspective, the implementation of the exercise shortly after
weaning was novel; however, the results of this study did not show any positive
neuroprotective benefit from exercise throughout the post-weaned lifespan of the
animal.
One of the premises of the study was that forced running, because of an aversive
electrical stimulus, would be traumatic to the animal and that this would create a
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stressful milieu that would reduce the neuroprotective effect of exercise as was shown
in the Howells et al (2005) study (Howells et al., 2005). In accordance with Howells et al
(2005), Smith et al (2002) hypothesized that stress may actually endanger dopaminergic
neurons, thereby potentiating dopamine attrition (Smith et al., 2002). Thus, this study
was designed with a comparative-control design that would hopefully clear up the
hypothesis that exercise was truly neuroprotective; the other main premise of the
study. Two exercise modalities, forced (i.e., stressful) and voluntary (i.e., non-stressful),
were compared to a no exercise control and a no exercise sham control. If stress was
indeed deleterious and if exercise was neuroprotective, then we would have expected
to see the voluntary running group with forelimb placement symmetry similar to or
close to the sham group and the forced running group with behavioral asymmetry
similar to or close to the no exercise control group. Neither of these happened in the
present study. Instead, there were no statistically significant differences among the
forced running, voluntary running and control for any of the motor behavior tests
suggesting no treatment effect of the exercise and no deleterious effect in the
“stressful” forced running group. These three groups did have significantly more
behavioral asymmetry than the sham group which suggests that they all had significant
motor signs and asymmetry consistent with the 6-OHDA-induced PD model. Based on
the results of this study, neither of the two main premises (i.e., exercise is
neuroprotective, forced exercise is deleterious) of this study were upheld.
Since there appears to be differences in the means of all three behavioral tests
(not statistically significant) that are somewhat consistent with exercise being
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neuroprotective (Figure 15-17), it is plausible that a type 2 error may have occurred
since the study was clearly underpowered. That is, exercise may be neuroprotective but
the treatment effect was so small that it would require a much larger sample size to
realize a statistically significant difference. Using the effect size indices in the present
study (apomorphine rotations f = 0.309; forelimb placement asymmetry f = 0.124;
exploratory rearing f = 0.161) and 80% power estimate, it would require the following
approximate sample sizes for differences to become statistically significant for the two
exercise groups and the control (sham was not factored into the estimate):
apomorphine rotations (36 rats per group; 108 rats total); forelimb placement
asymmetry (322 rats per group; 966 rats total); and, exploratory rearing (144 rats per
group; 432 rats total). Based on the results of the present study, either there is no
treatment effect at all (i.e., exercise is not neuroprotective) or there is only a small
treatment effect (i.e., mildly neuroprotective). The latter would represent a type 2 error
since we did not find a statistically significant difference among the three 6-OHDA
lesioned groups; however, powering a study to verify this would be implausible with
sample size estimates ranging from 108 to 966 total rats needed. Moreover, the risk-tobenefit ratio in light of animal mortality would not be warranted given the mild
treatment effect.
One of the expectations of this study was that the rats in the voluntary running
group would run more on their running wheel than the forced running group would on
the treadmill. What was not expected, however, was how much more the voluntary
running group would run. On average, the voluntary running rats ran more than 3.5
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kilometers per day before the 6-OHDA lesion, whereas the forced rats averaged less
than 500 meters per day before the 6-OHDA lesion, almost a seven fold difference in the
dosing of exercise (Figure 19). Clearly the forced exercise group could have tolerated
more exercise; however, this would have been difficult considering the man power
necessary to the run the animals for that length of time (i.e., at least 3.5 more daily
hours per rat). In addition, after the 6-OHDA lesion in the week before the last motor
behavior test, the voluntary rats ran on average 10 times more than the forced rats in
the same period, >2,000 meters and <200 meters per day, respectively. If exercise was
truly neuroprotective, then a dose dependent neuroprotective relationship in the motor
behavior tests would have likely been observed. That is, if exercise was beneficial, it
would have been expected that the forced running group would have less motor
impairment than the no exercise control group and an even greater amelioration of
motor impairment in the voluntary running group. Since this clearly did not happen in
the present study, the logical conclusion is that exercise does not afford a
neuroprotective benefit.
The trajectory of voluntary running over the course of the study (6 weeks prelesion and 1 week post-lesion) show a gradual increase in running over time until the 6OHDA lesioning and a decrease after surgery (Appendix, Figure 20). Thus, as the rats got
older and more acclimatized to the running wheel they began to run more. This is not
fully consistent with Peng et al (1980) who demonstrated that rats decrease running
activity as they age (Peng et al., 1980); though, it should be noted that the rats in that
study were older than the rats in the present study when they started their running.
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Whether they were running faster or for longer durations or both in comparison to the
forced exercise group is not known as this was not specifically tracked. As rats are
nocturnal, it is not surprising that the majority of their running episodes occurred in the
dark cycle. Unfortunately, this too was not documented; however, qualitatively, it was
the observation of the research team that the rats did not run during the day and this is
consistent with the literature which shows running activity is about 80% nocturnal (Peng
et al., 1980). The volume of the running in the voluntary group was also remarkable
(Appendix, Figure 21). Five of the ten rats averaged more than 4 kilometers of running
per day and one of these averaged 7 kilometers per day. The rat that ran the least still
ran more than twice the average distance of the forced exercise rats. While the
distances in voluntary running seem quite high, rats are known to be fairly prodigious
voluntary runners with one documented case as high as 43 kilometers in a 24 hour
period (Richter, 1927). Since rats are clearly capable of much greater distances than
forced treadmill exercise protocols permit and since forced exercise typically uses
aversive stimuli to condition the running the running behavior, it is recommended that
this approach to exercise in rodents become obsolete.
The secondary analysis of the correlation between the immediate post-operative
observation of right neck turning and the motor behavioral tests conducted a week later
suggests that this observation is indeed related to the severity of the neurotoxic 6OHDA lesion (Table 20). The more profound the right neck turns immediately after
surgery, the more apomorphine rotations, the higher the preference for use of the
unimpaired forelimb, and the fewer exploratory rearing episodes. Based on these
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findings, this novel observation, that has not been previously reported in the literature,
can be used as an immediate indicator of successful placement of the neurotoxin 6OHDA in the medial forebrain bundle. The fact that this observation begins almost
immediately (within 10-15 minutes) post-operatively suggests that this neurotoxin has
an almost immediate damaging effect on the nigrostriatal fibers. However, it is known
that 6-OHDA toxicity may be quite protracted and does not realize its full neurotoxic
potential for up to 28 weeks after injection (Bjorklund et al., 1997); so, clearly it is just
an early indicator of 6-OHDA toxicity to the medial forebrain bundle.
The secondary analysis of weight gain throughout the study suggests that all of
the rats, regardless of group assignment, had the same trajectory of weight gain over
the course of the study (Table 21, Figure 18). The general weight gain trajectory in the
present study was consistent with the Kretschmer et al (2005) study (Kretschmer et al.,
2005). However, in the Kretschmer et al (2005) study, rats who exercised for 12 minutes
daily reduced their body weight over time. This did not happen in the present study.
Presumably, the rats in the two groups with an exercise component (i.e., voluntary,
forced) must have had a compensatory increase in food consumption to keep up with
the increased metabolic demand from the exercise. Likewise, it is likely that the two
none exercise groups (i.e., control, sham) did not consume as much because the
metabolic demand of sedentary behavior was not as high as the exercise groups.
However, these assumptions are speculative as the amount of food and fluid intake was
not observed or recorded. All rats had access to standard laboratory chow ad libitum;
so, it is logical that food intake may have been compensatory depending on the energy
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expenditure and metabolic demand of their daily tasks. The literature is not consistent
on this point. Kretschmer et al (2005) showed no compensatory food intake in
exercised rats (Kretschmer et al., 2005); however, Levin and Dunn-Meynell (2004) found
that food intake was increased in exercising rats and Peng et al (1980) found a
compensatory increase in food intake with voluntary running (Levin & Dunn-Meynell,
2004; Peng et al., 1980). The Kretschmer et al (2005) study used a time limited
swimming regimen, whereas, the Levin and Dunn-Meynell (2004) study used rats that
had free access to a running wheel, much like the voluntary running regimen in the
present study (Kretschmer et al., 2005; Levin & Dunn-Meynell, 2004). Monitoring the
weight gain was an important consideration in the design of the present study because
if there were a significant differential pattern of growth of the animal in the different
groups it could mean that the stereotaxic coordinates of the 6-OHDA injection may not
have been in the same area of the medial forebrain bundle. Considering the inherent
variability of stereotactic injections and variability in the size and shape of head, another
source of potential error (i.e., difference size of the animal) would have been a threat to
the internal validity of the study.

CONCLUSION
A 6-week preconditioning of forced and voluntary exercise did not afford
neuroprotection to recently weaned, 6-OHDA-lesioned rats in terms of motor behavioral
tests. Voluntary exercising, which had a 10 fold increase in exercise dosing compared to
forced exercising was not better in terms of protection from motor behavioral
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asymmetry than forced exercise. In addition, neither was better than a no exercise
control. These results are not consistent with the body of literature on neuroprotection
and suggest that there is no consensus on the premise that exercise is neuroprotective.
Since the present study casts some doubt on the role of exercise as a neuroprotective
agent, further research is warranted.
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CHAPTER 5
SUMMARY, SIGNIFICANCE, AND FUTURE STUDIES

The concept of neuroprotection in the neurodegenerative diseases (e.g., PD,
Alzheimer’s disease (AD)) has been at the forefront of the research agenda for
neuroscientists for decades. It hinges on the theory that these neurodegenerative
diseases have an onset later in life and that the disease course (i.e., neurodegeneration)
could possibly be prevented or lessened by employing a treatment before the onset of
the disease. Many in the neurodegenerative research community have called the
search for a viable neuroprotective agent the “holy grail” of research in PD and AD.
Over the last few decades, PD researchers have investigated many putative
neuroprotective agents with limited success. Because PD is thought to cause attrition of
dopaminergic neurons through oxidative stress, many of these attempts have focused
on agents that have strong antioxidant properties (e.g., Coenzyme Q10, creatine)
(LeWitt, 2006; Mounsey & Teismann, 2010). Most of these studies met mild or
unremarkable results; yet the search for neuroprotective agents continues. This
dissertation was yet another attempt on a promising neuroprotective treatment that is
inexpensive, easy to implement, free from serious side effects, and has a multitude of
other robust benefits to many systems of the body: exercise.
The overarching premise of this dissertation was that exercise was
neuroprotective in a rat of model of PD. It was based on several studies from rodent PD
models that all reported strong treatment effects from exercise in terms of motor
protection and positive changes to the underlying dopaminergic pathways (Cohen et al.,
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2003; Howells et al., 2005; Tillerson et al., 2003; Tillerson et al., 2001). Despite this fairly
strong and consistent evidence from the literature, the results of the studies in this
dissertation do no support these findings. In fact, the findings of the present study cast
doubt on the role of exercise as a neuroprotective agent. From a clinical perspective,
the results of this study are a disappointment for patients with PD and clinicians who
treat patients with PD; however, they do suggest that more research is needed and this
could potentially open up new lines of evidence about the underlying disease process of
PD. Clearly, the notion that exercise slows the neurodegeneration in PD is premature.
When taking into account the differences in the designs of the three studies in
this dissertation to those that this research was based on, it is clear that there were
some small variations in design; however, they do not represent significant departures
in dosing, duration, intensity and housing (Table 22). Instead, an argument could be
made that the designs in this dissertation were more rigorous from an exercise
perspective than the majority of studies. While it might be appropriate to dissect and
scrutinize the differences between the studies, it is also important to understand that if
exercise were truly neuroprotective, minor departures (mostly in the direction of
increased dosing and intensity) should not negate the neuroprotective effects of
exercise. Thus, if exercise were truly neuroprotective as the body of literature suggests
then increasing the exercise regimen should actually produce a more robust
neuroprotective effect. On the other hand, it could be argued that the differences in
design and protocol may have introduced confounding effects that negated the
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protection. In either case, if exercise is truly neuroprotective then its positive protective
effect should not be so fragile.
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Table 22. Design characteristics of the literature on neuroprotection in 6-OHDA models
of Parkinson’s disease.
Study

Design

Comparison

Exercise
dose

Exercise
duration
Post: 4
weeks

Other
Exercise group
had more BrdU
+ cells in
striatum
Running
occurred
during the dark
cycle

Housing
Housed
two per
cage

Tajiri et
al, 2010

Neuroplasticity

Forced vs. control

5 days/week
30 min/day
11 m/minute

Tillerson
et al,
2003

Neuroplasticity

Forced vs. Sham
control vs. lesion
control

Daily?
30 min/day
15m/minute

Post: 4
weeks

Unimpaired
forelimb casting

Post: 1
week?

Housed in
groups of 3

Impaired
forelimb casting

Post: 1
week

Housed in
groups of 3

Tillerson
et al,
2001

Neuroplasticity

Tillerson
et al,
2002

Neuroplasticity

Forced (3 start
times) vs. Control
vs. Sham (3 start
times)
Forced non-use
vs. Sham vs.
Control

O’Dell et
al, 2007

Neuroprotection
and
Neuroplasticity

Forced+Voluntary
vs. Control

Pre: 10.5
m/min
30 min/day
Running wheel
Post: 6m/min
30 min/day
Running wheel

Cohen et
al, 2003

Neuroprotection

Forced vs. Sham
vs. Control

Impaired
forelimb casting

Pre: 1
week

Mabandla
et al,
2004

Neuroprotection
and
neuroprotection

Voluntary vs.
control

Access to
running wheel

Pre: 1
week
Post: 2
weeks

Pre: 5388
revolutions/day
Post: 4361
revolutions/day

Individually

Howells
et al,
2005

Neuroprotection
and
neuroplasticity

Stressed
voluntary vs.
Voluntary vs.
Control

Access to
running wheel

Pre: 1
week
Post: 2
weeks

Pre average
distance: 2182
meters/day
Post: 2140
meters/day

Individually

Aim 1

Neuroplasticity

Forced vs.
Control

5 days/week
30 min/day
15 m/minute

Post: 4
weeks

450
meters/day

Individually

Aim 2

Neuroprotection

Forced vs.
Control

5 days/week
30 min/day
15 m/minute

Pre: 4
weeks

450
meters/day

Individually

Aim 3

Neuroprotection
and
neuroplasticity

Forced vs.
Voluntary vs.
Sham control vs.
Lesion control

6 days/week
30 min/day
15 m/minute

Pre: 6
week
Post: 1
weeks

Forced: 450
meters/day
Voluntary:
3500
meters/day

Individually
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Pre: 2.5
weeks
Post: 4
weeks

No
preservation of
dopamine
terminals
Most rats ran
>1000
meters/day

Individually

Housed
two per
cage

As the dissertation evolved, three other premises emerged that helped guide the
design of the study in Chapter 4. First, a “true” neuroprotective design would
implement exercise before the injection of the neurotoxin (i.e., before disease onset).
However, the body of literature on the neuroprotective effect of exercise in PD has
almost uniformly been implemented in animals after neurotoxic insult (Cohen et al.,
2003; Howells et al., 2005; Tillerson et al., 2003; Tillerson et al., 2001). Technically, this
is not “neuroprotection” in any sense but rather “neuroplasticity” or “neurorecovery”
because the exercise was implemented after the onset of the disease. While it has been
convention to use the term “neuroprotection” in these studies, it is misleading. There
have been only a few studies that have used a true “neuroprotection” design, wherein
an exercise program was administered prior to neurotoxic insult using PD rodent models
(Cohen et al., 2003; Mabandla et al., 2004; O'Dell et al., 2007). Therefore, Chapter 2
was technically a “neuroplasticity” design and Chapters 3 and 4 were designed with
“neuroprotection” in mind. Since there are very few true “neuroprotective” designs
with exercise and PD in the literature, Chapters 3 and 4 were fairly novel.
Another important premise in the design of the study in Chapter 4 was that
implementation of exercise in young, recently weaned rats would potentially produce
more robust outcomes. Using rats so young was also a novel design element as this has
not been reported in the literature. Almost all of the published studies on the effect of
exercise on symptoms and neurobiology in rat PD models have used older rats. The
reasons for this are not entirely clear. However, one prominent researcher in the field
(Timothy Schallert, personal communication) suggested that younger rats are much
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more tolerant to the toxin 6-OHDA the Parkinsonian behavioral symptoms. While using
older rats would make sense for a study that has incorporated a “neuroplasticity” design
wherein the rats are exercised after neurotoxin-induced PD, it does not make sense in a
“neuroprotection” design wherein rats are exercised before neurotoxin-induced PD.
Unfortunately, neuroprotection studies in PD have almost uniformly used adult rats.
This is akin to having humans start an exercise program later in life with the hopes that
it will be protective. Perhaps an important “window of opportunity” may have been
missed by not starting exercise earlier during brain development. While
implementation of exercise in adult rats certainly makes sense from a neuroprotective
perspective, these designs may not capture the true neuroprotective effect of exercise
throughout the life of the animal as they were all administered to adult rats as was done
in Chapter 3. For this reason, the purpose of the study in Chapter 4 was to explore this
potential window of opportunity by implementing exercise to recently weaned rat pups.
Since it is conventionally thought that young rats are more resistant to the neurotoxin 6OHDA, the exercise period was lengthened to 6 weeks so that these recently weaned
rats would be adults when they were injected with the neurotoxin. If you consider the
three studies in this dissertation, older adult rats (Chapters 2 and 3) had considerably
more PD behavioral symptoms than the younger adult rats in Chapter 4. While these
results would support the assertion that was made by Timothy Schallert (personal
communication), the overall findings of these studies suggest that exercise in either
adult or recently weaned rats is not neuroprotective in terms of motor behavioral
symptoms.
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The third premise that emerged in this dissertation and helped guide the design
of the study in Chapter 4 was that forced exercise, because of aversive conditioning (i.e.,
unpleasant encounters with an electrical grid at the back of the rodent treadmill), might
not afford neuroprotection because it stressed the animal. Stress has been implicated
as a key factor of neurodegeneration in PD (Smith et al., 2002). In addition, it has been
shown to negate the neuroprotective effect of exercise in a rat model of PD (Howells et
al., 2005). In order to determine if exercise itself was neuroprotective a novel design
would be necessary. First, an additional exercise modality (i.e., voluntary exercise) was
added to compare it to exercise within a stressful milieu (i.e., forced exercise). If
exercise was indeed neuroprotective and if stressed rats were less likely to benefit from
this neuroprotection, then this design element would have allowed some inference into
the true relationship between exercise and PD. This was the first study to compare
forced and voluntary exercise in the 6-OHDA model. Unfortunately, the results of this
study did not support exercise, either forced or voluntary, as a neuroprotective strategy
in this model of PD.
Other than the stress component of forced exercise, one of the key differences
between voluntary and forced exercise in animal models is that voluntary exercise
allows the animal flexibility in the timing and dosage of the exercise. Based on the
results of the study in Chapter 4, rats are capable of considerable amounts of running
when they are left to run at their own discretion (Table 27, Figures 20-21). This is in
contrast to Leasure and Jones (2008) who found that rats in a forced exercise condition
ran about the same distance as rats that voluntarily exercised; however, they also found
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that voluntary exercise rats ran faster and for less total time than rats that were forced
(Leasure & Jones, 2008). Since forced and voluntary exercise are different on so many
levels (i.e., dosing of exercise, time of day, aversion stimuli), it is an attractive area of
comparison. Leasure and Jones (2008) agree that comparing the neural and behavioral
effects of different forms of exercise, like forced and voluntary exercise, needs more
scientific attention (Leasure & Jones, 2008). From an internal validity perspective,
voluntary exercise is a more attractive modality for future exercise studies because it is
free from potential confounding variables that plague forced exercise, like exercising in
the less active cycle (i.e., light cycle), aversive stimuli (i.e., electrical shocks), and animal
handling variations associated with transfer to and from the treadmill.
One novel element of this dissertation was the analysis of exploratory rearing as
a behavioral surrogate of hypokinesia, which is a paucity of movement or abnormally
diminished motor activity. It was felt that the number of times an animal would rear for
exploration during a 10 minute time frame might possibly be an accurate indicator of
this common, human PD symptom (Dunnewold et al., 1998; Hoshiyama et al., 1994; van
Hilten et al., 1995; van Hilten et al., 1998). Hypokinesia, observed in this way, has not
previously been explored in the literature in rodent PD models. Only one study has
explored hypokinesia in 6-OHDA rats; however, they did so by measuring motor activity
for one minute using a photocell activity apparatus in rats with bilateral 6-OHDA
lesioning (Jolicoeur et al., 1991). These researchers did find hypokinesia to be a
prominent feature of the 6-OHDA symptom profile. This lends validity to the use of
exploratory rearing in this dissertation as a behavioral surrogate of hypokinesia.
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Moreover, the collective findings in this dissertation of this motor test suggest that this
test might be useful in future studies using the 6-OHDA model even in cases with only a
unilateral neurotoxic injection.
The results of this dissertation clearly show that exploratory rearing is a
prominent feature of 6-OHDA lesioning. In Chapter 2, exploratory rearing improved
over time after 6-OHDA lesioning (Figure 7, Table 8). In Chapter 3, exploratory rearing
decreased immediately after the 6-OHDA lesion (Figure 12, Table 14). In Chapter 4,
exploratory rearing was significantly higher in the sham lesion group compared to the
three groups that had the 6-OHDA lesion (Table 19, Figure 17). In addition, in Chapters
3 and 4, exploratory rearing was significantly correlated to two of the most commonly
used behavioral tests in rat PD model research, apomorphine rotations and forelimb
placement asymmetry (Tables 15 and 20). Taken together, these results lend validity to
exploratory rearing as a useful assessment tool for hypokinetic behavior in rat models of
PD.
Another novel observation in this study was the presence of an immediate right
neck turn after 6-OHDA lesioning before the animal had regained full consciousness.
This was transient and went away after an hour or so. This has not been documented in
the literature. During the first study (Chapter 2), it seemed that many of the rats had a
right neck turn within about 10 minutes after surgery (Figure 22). Since all of the rats
had a 6-OHDA injection into the region of the right medial forebrain bundle, it was
logical that this right neck turn could be related to the surgery. From a neurophysiologic
perspective, this might suggest that the neurotoxin is immediately taken up by
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nigrostriatal fibers destined for the right striatum. Because the right striatum reinforces
motor facilitation in the contralateral half of the body, toxic insult to this pathway would
logically cause a decrease in striatal-reinforced motor facilitation in the left side of the
animal, including the neck sidebending musculature that would cause the neck to move
to the left. Concomitantly, a decrease in muscular facilitation on the left would be met
by a relative increase in motor facilitation on the right causing the right neck turn. Over
time, the animal, when fully conscious, would be able to make corrective centering of
the head during routine behavioral activities and, thus, would be able to overcome the
imbalanced motor facilitation through volitional control.
It was felt that the immediate but transient right neck turn could possibly be an
early indicator of successful neurotoxin placement into the right medial forebrain
bundle. Since some of the rats did not have this right neck turn, it was thought that
perhaps the stereotactic injection of the neurotoxin did not reach its mark. Since this
was just a theory, observation of it was standardized in Chapters 3 and 4. In Chapter 3,
moderate to strong correlations were found with this immediate postoperative
observation to apomorphine rotations, forelimb placement asymmetry and exploratory
rearing (point biserials = 0.734, 0.534, and -0.749, respectively). Thus, this immediate
right neck turn was indeed related to the severity of the Parkinsonian behavioral
asymmetries. Moderate correlations, consistent with Chapter 3 results, were also
observed in Chapter 4. Taken together, the immediate observation of postoperative
right neck turn is an early sign of successful neurotoxin injection into the medial
forebrain bundle. While it is a fairly well-established fact that 6-OHDA has a protracted
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neurotoxicity (Bjorklund et al., 1997), based on the results of the studies in this
dissertation, 6-OHDA has in the least an immediate neurotoxic effect on motor
facilitation.
There were several limitations in the design of this dissertation that may have
influenced the results. First, the experimental control of the designs could have been
improved. For instance, all of the rats should be exposed to the same time, type and
duration of handling procedures and other design related variations regardless of
experimental group. Consider the design of Chapter 4. The voluntary rats were housed
in different housing units than the other rats (i.e., housing units with free access to an
attached running wheel). Also, the forced rats were handled twice daily during their
forced running protocol. The voluntary, sham and control rats were not handled at all
except for weighing and cleaning housing units. Ideally, every rat should have been
housed in the same type of housing unit; the housing unit with the running wheel would
have been ideal for all of the rats in all of the conditions. However, in the conditions
were there were no running expectations then the wheel could have been immobilized.
In addition, all of the rats should have been exposed to the running treadmill with the
same frequency and duration as the forced runners; however, the treadmill belt would
not have been turned on for the other conditions. Second, housing the rats individually
could have been a potential stressful confounding factor. Rats could have been housed
in groups and then, in the case of the voluntary exercise, radiofrequency identification
technology could have been utilized to identify which rats were running, how long, and
how intense. Third, rats should be exercised during their more active cycle (i.e., the
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dark cycle). Since the rats in the voluntary exercise clearly exercised more during the
dark cycle it would stand to reason that the forced exercise should have taken place
during that same time.
Future designs investigating the effects of exercise in rodent model of PD should
consider some of the new transgenic and knockout models (i.e., rat and mouse) that
have recently emerged on the market. The majority of these mostly untested models
were not available at the time of this dissertation; however, they represent an
important development in rodent PD models and might afford a closer approximation to
human PD. In addition, rather than using a bolus delivery protocol for neurotoxin, as
was done in this dissertation, researchers should consider a slower delivery method
(e.g., Alzet pumps) to more closely approximate the slow, progressive
neurodegeneration seen in human PD (Alvarez-Fischer et al., 2008).
In summary, the results of the studies in this dissertation cast doubt on the
neuroprotective properties of voluntary and forced exercise in a 6-OHDA-induced
hemiparkinsonian model. Since the findings of this dissertation are clearly in contrast to
the body of literature on this topic, there is a need to further develop these hypotheses
using more rigorous designs. In the least, the results of this dissertation should add
some caution to the commonly held assumption in the neurodegenerative community
that exercise is neuroprotective in rat models of PD.
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Krum L, Schuerman S, Colton M, Fogg M, George S, Kocher K, Alpert P, Landers
M. Female college athletes: relationships of quadriceps angle, bone mineral
density, muscular strength, body composition, and calcium intake across sports.
American Physical Therapy Association Combined Sections Meeting, Boston,
Massachusetts, February 14-18, 2007.
Landers MR, Wulf G. Postural instability in idiopathic Parkinson’s disease:
predicting fallers from non-fallers based on standardized clinical measures. The
Movement Disorder Society’s 10th International Congress of Parkinson’s Disease
and Movement Disorders, Kyoto, Japan, Oct 28 – Nov 2, 2006.
McWhorter JW, Altenburger B, Wallmann HW, Landers MR. The effects of verbal
motivation on maximal isokinetic torque production in children. American
Physical Therapy Association Combined Sections Meeting, San Diego, California,
Feb 2006.
Landers MR, McWhorter JW, Filibeck D, Robinson C. Does sitting posture in
chronic obstructive pulmonary disease really matter?: an analysis of two sitting
postures and their effect on pulmonary and cardiovascular function. 2005
Annual Meeting of the American Association of Cardiovascular and Pulmonary
Rehabilitation (AACVPR). Milwaukee, Wisconsin, October 21, 2005.
Landers MR, Cheung W, Miller D, Summons T. A prospective investigation of the
effects of secondary gain in neck pain. 2nd International Conference on
Movement Dysfunction. Pain and Performance: Evidence & Effect. Edinburgh,
Scotland, United Kingdom, September 23-25, 2005.
Landers MR, Creger R, Baker C, Stutelberg K. An investigation of the predictive
ability of fear-avoidance beliefs and nonorganic signs in patients with neck pain.
The 2nd International Conference on Movement Dysfunction. Pain and
Performance: Evidence & Effect. Edinburgh, Scotland, United Kingdom,
September 23-25, 2005.
Nocera JR, Rubley MD, Holcombe WR, Guadagnoli MA, Landers MR. Effects of a
single bout of throwing on rotator cuff strength and proprioception. NATA
Annual Meeting, Indianapolis, Indiana, June 2005.
McWhorter JW, Berry K, Higbee C, Tompkins D, Altenburger P, Wallmann H,
Landers MR. The effects of loaded, unloaded, dynamic, and static activities on
foot volumetrics. American Physical Therapy Association Combined Sections
Meeting, New Orleans, LA, Feb 2005
Landers MR, McWhorter JW, Krum LL, Glovinsky D. A comparison of physical
therapist continuing education practices in states with and without mandatory
state continuing education requirements. American Physical Therapy
Association Combined Sections Meeting, Nashville, Tennessee, February 4-8,
2004.
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Landers MR, Baker CL, Stutelberg KS, Creger RV. Effectiveness of cervical
nonorganic signs in predicting disability in patients with neck pain. 8th Congress
of European Federation for Research in Rehabilitation, Ljubljana, Slovenia, June
13-17, 2004.
Landers MR, Creger RV, Stutelberg KS, Baker CL. Relationship of fear-avoidance
beliefs to functional limitation and secondary gain in a cohort of patients with
neck pain. American Physical Therapy Association Annual Conference and
Exposition, Chicago, Illinois, June 30 – July 2, 2004.
Landers MR, Wallmann HW. Differences between idiopathic Parkinson’s disease
fallers and non-fallers on computerized dynamic posturography measurements
and subscale scores of the Parkinson’s Disease Questionnaire (PDQ-39).
American Physical Therapy Association Annual Conference and Exposition,
Chicago, Illinois, June 30 – July 2, 2004.
Landers M, Wulf G, Wallmann H, Guadagnoli M. The effects of attentional focus
on balance in idiopathic Parkinson’s disease. Platform presentation. American
Physical Therapy Association Combined Sections Meeting, Washington, DC, June
17-22, 2003
McWhorter JW, Wallmann H, Landers M, Krum LL, Altenburger P, Altenburger B.
The effects of walking, running, and shoe size on foot volumetrics. Posture
presentation. American Physical Therapy Association Combined Sections
Meeting, Washington, DC, June 17-22, 2003.
Landers M, Wulf G, Wallmann H, Guadagnoli M. An external focus of attention
can attenuate balance impairment in Parkinson’s disease. Posture presentation.
Annual Meeting of the North American Society for the Psychology of Sport and
Physical Activity (NASPSPA), Savannah, GA, June 5-7, 2003.

INVITED PRESENTATIONS
• Landers MR. Neck pain-related disability: current evidence on clinical correlates
and conservative treatment options. 28th Annual National Workers’
Compensation and Occupational Medicine Conference. Hyannis, Massachusetts,
July 14-17, 2008.
• Landers M. Update on peripheral nerve injury. 41st Annual Conference of the
Indian Association of Physiotherapists, Mumbai (Bombay), India, January 1 –
February 2, 2003.
RESEARCH GRANTS
• Keil DE, Klaassen JM, Landers MR, Elekonich M, McWhorter JM, Peden-Adams
M.. Establishing a clinical research infrastructure. Clinical Research Core (CRC)
Laboratory: Support for Interdisciplinary Studies in Health Sciences. Research
Infrastructure Award Program. UNLV. 2007, $100,000, funded
• Menzel N, Landers MR, Keil D. Biomarkers for low back pain-related disability.
Research development Award. UNLV. 2007. $9,514, funded
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Landers M, Patton P, de Belle S. An investigation of the neuroplastic changes in
subcortical brain pathways associated with Parkinson’s disease using positron
emission tomography. UNLV SITE Grant. 2005. $7,500, funded
Wulf G, Landers M. Attentional focus training to enhance balance in individuals
with Parkinson’s disease. American Parkinson’s Disease Association. 2004.
$50,000, funded
LaPorta L, McWhorter JW, and Landers M. Acquisition of equipment to support
DEXA scan research. UNLV SITE Grant. 2002. $4,685, funded
Landers M, and McWhorter JW. A Comparison of Continuing Education Practice
in States with and without Mandatory Continuing Education Requirements. New
Investigator Award, University Research Council, University of Nevada, Las
Vegas. 2002. $4,444.00, funded

MANUSCRIPT REVIEWER
• Physical Therapy Journal, 2006 to present
• Physiotherapy Journal, 2008 to present
• Gait & Posture, 2009 to present
• Journal of Neurologic Physical Therapy, 2010 to present
• Parkinson’s Disease and Related Disorders, 2011
• Stroke, 2011
• Journal of NeuroEngineering and Rehabilitation, 2011
• Journal of Manipulative and Physiologic Therapeutics, 2009
• Archives of Physical Medicine and Rehabilitation, 2009
• Physiology & Behavior, 2008
• Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 2007
GRANT REVIEWER
• University of Utah Center on Aging (CoA) Pilot Grant Program, 2011
• National Institute of Neurological Disorders and Stroke (Neurological Sciences
and Disorders K Panel (NSD-K)), 2011
• National Institute of Neurological Disorders and Stroke (Neurological Sciences
and Disorders K Panel (NSD-K)), 2010
• Parkinson’s Disease Society UK, 2008
PROFESSIONAL MEMBERSHIP
• Member American Physical Therapy Association (1994 – present)
• Member Nevada Physical Therapy Association (1997 – present)
• Member Orthopedic Section of the American Physical Therapy Association (1995
– present)
• Member Education Section of the American Physical Therapy Association (2003 –
present)
• Member Neurology Section of the American Physical Therapy Association (2004
– present)
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Member Research Section of the American Physical Therapy Association (2004 –
present)
Member International Society for Posture & Gait Research (2011 – present)

PROFESSIONAL SERVICE
• Advisory Board – Pima Medical Institute Physical Therapist Assistant Program,
7/2011
• Awards Committee - Subcommittee on Publications, American Physical Therapy
Association, 7/2010 - 6/2014
• Institutional Review Board Member, Lou Ruvo Brain Institute (Alzheimer’s
disease and movement disorders), Las Vegas, Nevada, 2009
• NPTA Research Committee Chair (2001 to 2010)
• Parkinson’s Disease Conference Planning Committee (2002 – 2005)
• Continuing Education Chair Nevada Physical Therapy Association (2000 – 2002)
• Continuing Education Co-Chair Nevada Physical Therapy Association (1999 –
2000)
• Program/Education Committee Southern District Chair (1999 – 2002) NPTA
• NPTA Ethics Committee (2000 to 2002)
• Clinical Instructor for UNLV – 2000
• Clinical instructor for CSN – 1999
AWARDS
• 2011 Cyrus Tang Research Award.
• 2011 Wound Management SIG Research Award (APTA)
• 2010 UNLV Travel Award.
• 2009 eLayne Library Verve Award for Parkinson’s disease research.
• 2008 UNLV Travel Award.
• 2006 UNLV Travel Award.
• 2005 Faculty Development Award. Nevada Geriatric Education Center.
• 2005 UNLV Travel Award.
• 2003 Nevada Physical Therapy Association Leadership Award
• 2002 New Investigator Award, University Research Council, University of Nevada,
Las Vegas
• Orthopedic Certified Specialist (OCS) by the American Board of Physical Therapy
Specialties (2001), #4628
• 2000 Nevada Physical Therapy Association Award of Merit
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